key: cord-0646396-vt5avt47
authors: Borusyak, Kirill; Jaravel, Xavier; Spiess, Jann
title: Revisiting Event Study Designs: Robust and Efficient Estimation
date: 2021-08-27
journal: nan
DOI: nan
sha: 2d6029fff31a6741e76fdea44e04c02582ee9767
doc_id: 646396
cord_uid: vt5avt47

We develop a framework for difference-in-differences designs with staggered treatment adoption and heterogeneous causal effects. We show that conventional regression-based estimators fail to provide unbiased estimates of relevant estimands absent strong restrictions on treatment-effect homogeneity. We then derive the efficient estimator addressing this challenge, which takes an intuitive"imputation"form when treatment-effect heterogeneity is unrestricted. We characterize the asymptotic behavior of the estimator, propose tools for inference, and develop tests for identifying assumptions. Extensions include time-varying controls, triple-differences, and certain non-binary treatments. We show the practical relevance of these insights in a simulation study and an application. Studying the consumption response to tax rebates in the United States, we find that the notional marginal propensity to consume is between 8 and 11 percent in the first quarter -- about half as large as benchmark estimates used to calibrate macroeconomic models -- and predominantly occurs in the first month after the rebate.

Event studies are one of the most popular tools in applied economics and policy evaluation. An event study is a difference-in-differences (DiD) design in which a set of units in the panel receive treatment at different points in time. In this paper, we investigate the robustness and efficiency of estimators of causal effects in event studies, with a focus on the role of treatment effect heterogeneity. We first develop a simple econometric framework that delineates the identification assumptions from each other and from the estimation target, defined as some average of heterogeneous causal effects. We then apply this framework in three ways. First, we analyze the conventional practice of implementing event studies via two-way fixed effect (TWFE) regressions and show how the implicit conflation of different assumptions leads to biases. Second, leveraging event study assumptions in an explicit and principled way allows us to derive the robust and efficient estimator, along with appropriate inference methods and tests. The estimator takes an intuitive "imputation" form when treatmenteffect heterogeneity is unrestricted. Finally, we illustrate the practical relevance of our approach in an application estimating the marginal propensity to consume (MPC) out of tax rebates; our MPC estimates are lower than in prior work, implying that fiscal stimulus is less powerful than commonly thought.

Event studies are frequently used to estimate treatment effects when treatment is not randomized, but the researcher has panel data allowing them to compare outcome trajectories before and after the onset of treatment, as well as across units treated at different times. By analogy to conventional DiD designs without staggered rollout, event studies are commonly implemented by two-way fixed effect regressions, such as

where outcome Y it and binary treatment D it are measured in periods t and for units i, α i are unit fixed effects (FEs) that allow for different baseline outcomes across units, and β t are period fixed effects that accommodate overall trends in the outcome. Specifications like (1) are meant to isolate a treatment effect τ from unit-and period-specific confounders. A commonly-used dynamic version of this regression includes "lags" and "leads" of the indicator for the onset of treatment, to capture the dynamics of treatment effects and test for the parallel trajectories of the pre-treatment outcomes.

To understand the problems with conventional two-way fixed effect estimators in event-study designs and provide a principled econometric approach to overcoming these issues, in Section 2 we develop a simple framework that makes the estimation targets and underlying assumptions explicit and clearly isolated. We suppose that the researcher chooses a particular weighted average (or weighted sum) of heterogeneous treatment effects they are interested in estimating. We make (and later test) two standard DiD identification assumptions: that potential outcomes without treatment are characterized by parallel trends and that there are no anticipatory effects. We also allow for -but do not require -an auxiliary assumption that the treatment effects themselves follow some model that restricts their heterogeneity for a priori specified economic reasons. This explicit approach is in contrast to regression specifications like (1), both static and dynamic, which implicitly conflate choices of estimation target and identification assumptions. Our framework covers a broad class of empirically relevant estimands beyond the standard average treatment-on-the-treated (ATT), including ATTs at different horizons that hold the composition of units fixed and differences in ATTs across groups of units.

Through the lens of this framework, in Section 3 we uncover a set of challenges with conventional regression-based event study estimation methods and trace them back to a lack of clearly stated or separated estimation target and identification assumptions. First, we note that failing to rule out anticipation effects in "fully-dynamic" specifications (with all leads and lags of the event included) leads to an underidentification problem when there are no never-treated units, such that the dynamic path of anticipation and treatment effects over time is not point-identified. We conclude that it is important to separate out testing the assumptions about pre-trends from the estimation of dynamic treatment effects under those assumptions. Second, implicit assumptions of homogeneous treatment effects embedded in static DiD regressions like (1) may lead to estimands that put negative weights on some long-run treatment effects. With staggered rollout, regression-based estimation leverages comparisons between groups that got treated over a period of time and reference groups which had been treated earlier. We label such cases "forbidden comparisons." Indeed, these comparisons are only valid when the homogeneity assumption is true; when it is violated, they can substantially distort the weights the estimator places on treatment effects, or even make them negative. Third, in dynamic specifications, implicit assumptions about treatment effect homogeneity across groups first treated at different times lead to the spurious identification of long-run treatment effects for which no DiD comparisons valid under heterogeneous treatment effects are available. The last two challenges highlight the danger of imposing implicit treatment effect homogeneity assumptions instead of allowing for heterogeneity and explicitly specifying the target estimand. We show that these challenges are not resolved by trimming the sample to a fixed window around the event date.

From the above discussion, the reader should not conclude that event study designs are plagued by fundamental problems. On the contrary, these challenges only arise due to a mismatch between the regression estimators and the underlying assumptions. We therefore use our framework to circumvent these issues and derive robust and efficient estimators.

In Section 4, we first establish a simple characterization for the most efficient linear unbiased estimator of any pre-specified weighted sum of treatment effects, in the baseline case of homoskedasticity.

This estimator explicitly incorporates the researcher's estimation goal and assumptions about parallel trends, anticipation effects, and restrictions on treatment effect heterogeneity. It is constructed by estimating a flexible high-dimensional regression that differs from conventional event study specifications, and aggregating its coefficients appropriately. While homoskedasticity is only a natural starting point, the principled construction of this estimator yields attractive efficiency properties more generally, as we confirm in simulations. We find that the estimator has sizable efficiency advantages: the variances of alternative robust estimators are 15-43% higher under homoskedasticity and these gains are preserved under heteroskedasticity and serial correlation of errors. Moreover, we find that the robustness of our estimator comes at little efficiency cost relative to dynamic ordinary least squares (OLS) estimators.

In our leading case where the heterogeneity of treatment effects is not restricted, the efficient robust estimator can be implemented using a transparent "imputation" procedure. First, the unit and period fixed effectsα i andβ t are fitted by regressions using untreated observations only. Second, these fixed effects are used to impute the untreated potential outcomes and therefore obtain an estimated treatment effectτ it = Y it −α i −β t for each treated observation. Finally, a weighted sum of these treatment effect estimates is taken, with weights corresponding to the estimation target.

To relate our efficient imputation estimator to other unbiased estimators that have been proposed in the literature, we derive two additional results showing the generality of the imputation structure.

First, any other linear estimator that is unbiased in our framework with unrestricted causal effects can be represented as an imputation estimator, albeit with an inefficient way of imputing untreated potential outcomes. Second, even when assumptions that restrict treatment effect heterogeneity are imposed, any unbiased estimator can still be understood as an imputation estimator for an adjusted estimand. Together, these two results allow us to characterize estimators of treatment effects in event studies as a combination of how they impute unobserved potential outcomes and which weights they put on treatment effects.

For the efficient estimator in our framework, we provide tools for valid inference. Specifically, we derive conditions under which the estimator is consistent and asymptotically Normal and propose standard error estimates. Inference is challenging under arbitrary treatment effect heterogeneity, because causal effects cannot be separated from the error terms. We instead show how asymptotically conservative standard errors can be derived, by attributing some variation in estimated treatment effects to the error terms. Our inference results apply under mild conditions in short panels. Advancing the existing literature on DiD estimation with staggered adoption, we also provide conditions for consistency and inference that extend to panels where the number of time periods grows, as long as growth is not too fast. We also propose a leave-one-out modification to our conservative variance estimates with improved finite-sample performance.

In addition, we provide a principled way of testing the identifying assumptions of parallel trends and no anticipation effects, based on OLS regressions with untreated observations only. Compared to conventional OLS regressions with leads and lags of treatment, this approach avoids the contamination of the tests by treatment effect heterogeneity shown by Sun and Abraham (2021) . Moreover, relative to placebo-based tests (e.g., de Chaisemartin and D'Haultfoeuille, 2021), our strategy avoids a power loss in testing and circumvents the pre-testing problems pointed out by Roth (2019) , under homoskedasticity. These attractive properties result from the clear separation of estimation and testing with our approach.

While our baseline setting is for panel data with two-way fixed effects, we show how our formal results extend naturally in a number of ways. We allow for more general panel-type specifications that can include, for instance, unit-specific trends and time-varying covariates. In Section 5 we consider extensions to repeated cross-sections, data defined by two cross-sectional dimensions (e.g., regions and age groups), triple-differences designs, and other data structures. We further discuss the implications of our results when treatment is simultaneous rather than staggered, when it can switch on and off, and when multiple treatment events can happen in the same unit. Settings with non-binary treatments (i.e., variable treatment intensity) are also covered, provided each unit is observed without treatment in some earlier periods.

It is also useful to point out the limitations of our analysis. First, all event study designs assume a restrictive parametric model for untreated outcomes. We do not evaluate when these assumptions may be applicable, and therefore when the event study design are ex ante appropriate, as Roth and Sant'Anna (2020) do. We similarly do not consider estimation that is robust to violations of paralleltrend type assumptions, as Rambachan and Roth (2020) propose. We instead take the standard assumptions of event study designs as given and derive optimal estimators, valid inference, and practical tests to assess whether parallel-trend assumptions hold. Second, we also do not consider event studies as understood in the finance literature, based on high-frequency panel data, which typically do not use period fixed effects (MacKinlay, 1997) .

In Section 6, we illustrate the practical relevance of our theoretical insights by revisiting the estimation of the marginal propensity to spend (MPX) out of tax rebates in the event study of Broda and Parker (2014) . First, we show that the choice of a binned OLS specification used by Broda and Parker (2014) leads to a substantial upward bias in estimated MPXs. Indeed, we find that the binned OLS specification puts a large weight on the effects happening in the first week after the rebate receipt, and negative weights on some longer-run effects, biasing the estimate upwards because the spending response quickly decays over time. Second, we highlight that, due to the implicit extrapolation of treatment effects by the OLS estimator, some dynamic specifications could be mistakenly interpreted as evidence for a large and persistent increase in spending. Our imputation estimator eliminates unstable patterns found across OLS specifications. Third, we illustrate the underidentification problem with the fully-dynamic OLS specification: the dynamic path of estimates is very sensitive to the choice of leads to drop. Fourth, we find large efficiency gains of our imputation estimator relative to the alternative robust estimators: the confidence interval is about 50% longer for each week relative to the rebate for de Chaisemartin and D'Haultfoeuille (2021) , and 2-3.5 times longer for Sun and Abraham (2021).

Our findings deliver several insights for the macroeconomics literature. While commonly used estimates of the quarterly MPX covering all expenditures range from 50-90% and estimates of the quarterly MPX for nondurable expenditure range from 15-25%, 1 our estimates, when appropriately rescaled, are about half as large, at 25-37% for the MPX one quarter after tax rebate receipt for all expenditures and 8-11% for nondurables. Using the scaling methodology of Laibson et al. (2022) ,

we estimate that the model-consistent, or "notional," MPC in the quarter following the tax rebate ranges between 7.8% and 11.4%, compared with 15.9% to 23.4% in the original estimation of Broda and Parker (2014) . Furthermore, our preferred estimates are much more short-lived than benchmark estimates, falling to a statistical zero beyond the first month after receiving the tax rebate. Thus, our new estimates imply that fiscal stimulus may be less potent than predicted by leading macroeconomic models targeting benchmark estimates. 2

For convenient application of our results, we supply a Stata command, did_imputation, which implements the imputation estimator and inference for it in a computationally efficient way. Our command handles a variety of practicalities, such as additional covariates and fixed effects, observation weights, and repeated cross-sections. We also provide a second command, event_plot, for producing "event study plots" that visualize the estimates with both our estimator and the alternative ones.

Our paper contributes to a growing methodological literature on event studies. To the best of our knowledge, our paper is the first and only one to characterize the underidentification and spurious identification of long-run treatment effects that arise in regression-based implementations of event study designs. The negative weighting problem has received more attention. It was first shown by de Chaisemartin and D'Haultfoeuille (2015, Supplement 1). The earlier manuscript of our paper (Borusyak and Jaravel, 2017) independently pointed it out and additionally explained how it arises because of forbidden comparisons and why it affects long-run effects in particular, which we now discuss in Section 3.3 below. The issue has since been further investigated by Goodman-Bacon Roth (2019) have further uncovered problems with conventional pre-trend tests, and Schmidheiny and Siegloch (2020) have characterized the problems which arise from binning multiple lags and leads in dynamic specifications. Besides being the first to point out some of these issues, our paper provides a unifying econometric framework which explicitly relates these issues to the conflation of the target estimand and the underlying identification assumptions.

Several papers have proposed ways to address these problems, introducing estimators that remain valid when treatment effects can vary arbitrarily (de Chaisemartin and D'Haultfoeuille, 2021; Sun and Abraham, 2021; Callaway and Sant'Anna, 2021; Marcus and Sant'Anna, 2020; Cengiz et al., 2019 ). An important limitation of these robust estimators is that their efficiency properties are not known. 3 A key contribution of our paper is to derive a practical, robust and finite-sample efficient estimator from first principles. We show that this estimator takes a particularly transparent form under unrestricted treatment effect heterogeneity, while our construction also yields efficiency when some restrictions on treatment effects are imposed. By clearly separating the testing of underlying assumptions from the estimation step imposing these assumptions, we simultaneously increase 2 In an independent study, Orchard et al. (2022) apply our imputation estimator to the Parker et al. (2013) setting and data, covering the full consumption basket, and also obtain estimates around half as large as in the original study. Because of the quarterly frequency of their data, their estimates are less precise and do not allow them to investigate the dynamics of the effect. See also Baker et al. (2021) for evidence that using robust, rather than regression-based, event study estimation matters in other empirical contexts.

3 A notable exception is Marcus and Sant'Anna (2020) , who consider a two-stage generalized method of moments (GMM) estimator and establish its semiparametric efficiency under heteroskedasticity in a large-sample framework with a fixed number of periods. However, they find this estimator to be impractical, as it involves many moments, e.g. almost as many as the number of observations in the application they consider. estimation efficiency 4 and avoid pre-testing bias under homoskedasticity. Our estimator uses all pre-treatment periods for imputation, as appropriate under the standard DiD assumptions, while alternative estimators use more limited information; see Section 4.5 for a detailed discussion. 5

Finally, our paper is related to a nascent literature that develops robust estimators similar to the imputation estimator. To the best of our knowledge, this idea has been first proposed for factor models (Gobillon and Magnac, 2016; Xu, 2017) . Athey et al. (2021) consider a general class of "matrix-completion" estimators for panel data that first impute untreated potential outcomes by regularized factor-and fixed-effects models and then average over the implied treatment-effect estimates. 6 In work independent from ours, the imputation idea has been explicitly applied to fixed-effect estimators in event studies by Liu et al. (2020) and Gardner (2021) . Specifically, the counterfactual estimator of Liu et al. (2020) , the two-stage estimator of Gardner (2021) , and a version of the matrix-completion estimator from Athey et al. (2021) without factors or regularization coincide with the imputation estimator in our model for the specific class of estimands their papers consider. Relative to these papers, we make four contributions: we derive a general imputation estimator from first principles, show its efficiency, provide tools for valid asymptotic inference when unit fixed effects are included, and show its robustness to pre-testing. Subsequently to our work, Wooldridge (2021) derives a two-way Mundlak estimator, which is also equivalent to the imputation estimator in complete panels with no controls and for a restricted class of estimands. The robustness and efficiency properties of our estimator are not limited to those situations.

We consider estimation of causal effects of a binary treatment D it on some outcome Y it in a panel of units i and periods t. We focus on "staggered rollout" designs, in which being treated is an absorbing state. That is, for each unit there is an event date E i when D it switches from 0 and 1 and stays there forever:

is the number of periods since the event date ("relative time"). We also allow that some units are never treated, denoted by E i = ∞. 7 Units with the same event date are referred to as a cohort.

We do not make any random sampling assumptions and work with a fixed set of N observations it ∈ Ω, which may or may not form a complete panel. We similarly view the event date for each 4 This efficiency gain relative to de Chaisemartin and D'Haultfoeuille (2021) and Sun and Abraham (2021) is obtained without stronger assumptions. Callaway and Sant'Anna (2021) restrict pre-trends only for some units and periods, which is technically a weaker assumption (see Marcus and Sant'Anna, 2020) . 5 A separate strand of literature has considered design-based inference with event studies, where randomness arises in the treatment assignment and timing, following a known model (Athey and Imbens, 2018; Roth and Sant'Anna, 2022; Arkhangelsky and Imbens, 2019) . Our identification and inference approach differs in that we condition on treatment timing and take the panel as given. With this approach, we follow Abadie et al. (2014) in focusing on an in-sample estimand, which in our case is a weighted sample average treatment effect for those observations that were actually treated.

6 Earlier work on synthetic controls (Abadie et al., 2010) and interactive fixed effects (Hsiao et al., 2012) features estimators with similar structure in settings with just one treated unit, in which treatment effect heterogeneity is not a main focus.

7 In principle always-treated units are also allowed for, by Ei = −∞, but in practice they will not be useful for causal identification with flexible treatment effect heterogeneity. unit, and therefore all treatment indicators, as fixed. We define the set of treated observations by Ω 1 = {it ∈ Ω : D it = 1} of size N 1 and the set of untreated (i.e., never-treated and not-yet-treated) observations by Ω 0 = {it ∈ Ω : D it = 0} of size N 0 . 8

We denote by Y it (0) the period-t (possibly stochastic) potential outcome of unit i if it is never treated. We are then interested in causal effects (0)] on the treated observations it ∈ Ω 1 . We suppose a researcher is interested in a statistic which sums or averages treatment effects τ = (τ it ) it∈Ω 1 over the set of treated observations with pre-specified non-stochastic weights w 1 = (w it ) it∈Ω 1 that can depend on treatment assignment and timing, but not on realized outcomes:

For notation brevity we consider scalar estimands. Different weights are appropriate for different research questions. The researcher may be interested in the overall ATT, formalized by w it = 1/N 1 for all it ∈ Ω 1 . In "event study" analyses a common estimand is the average effect h periods since treatment for a given "horizon" h ≥ 0:

Our approach also allows researchers to specify target estimands that place unequal weights on units within the same cohort-by-horizon cell. For example, one may be interested in weighting units by their size, or in estimating a "balanced" version of horizon-average effects: the average treatment effects at horizon h computed only for the subset of units also observed at horizon h , such that the gap between two or more estimates is not confounded by compositional differences. Finally, we do not require the w it to add up to one; for example, a researcher may be interested in the difference between average treatment effects at different horizons or across some groups of units (e.g. women and men), corresponding to it∈Ω 1 w it = 0. 9

To identify τ w , we consider three assumptions. We start with the parallel trends assumption, which imposes a two-way fixed effect (TWFE) model on the untreated potential outcomes.

Assumption 1 (Parallel trends). There exist non-stochastic α i and β t such that (0)] to be the same across units i for all periods t and t (whenever it and it are observed).

Parallel trend assumptions are standard in DiD designs, but their details may vary. 11 First, our framework extends immediately to richer models of Y it (0), which may include time-varying controls, 8 Viewing the set of observations and event times as non-stochastic is for notational convenience: Appendix A.10 shows how this framework can be derived from one in which both are stochastic, by conditioning on Ω and {Ei} i . Furthermore, our conditional framework avoids random sampling assumptions made in other work on DiD designs (e.g. de Chaisemartin and D'Haultfoeuille, 2020 , Sun and Abraham, 2021 , and Callaway and Sant'Anna, 2021 . In Appendix A.11 we show how the assumptions in this section can be derived from such population models; in this sense, our approach is more general since it nests common alternatives. 9 We note that in practice researchers are not always explicit about their estimand of interest and may be willing to work with any "reasonable" average of treatment effects, informally understood (e.g., no negative weights). In Section 3 we will show why specifying the estimand (or perhaps a class of estimands) is important.

10 In estimation, we will set the fixed effect of either one unit or one period to zero, such as β1 = 0. This is without loss of generality, since the TWFE model is otherwise over-parameterized. 11 A recent line of work by Athey and Imbens (2018) and Roth and Sant'Anna (2022) develops methods for causal inference in staggered adoption designs which do not require parallel trends, but are instead based on randomness unit-specific trends, or additional fixed effects (see Assumption 1 below). Similarly, it applies in settings where unit FEs are not appropriate, as with repeated cross-sections, or even if the data do not have a panel structure; see Section 5. Second, we impose the TWFE model on the entire sample. Although weaker assumptions can be sufficient for identification of τ w (e.g., Callaway et al., 2021) , those alternative restrictions depend on the realized treatment timing. Since parallel trends is an assumption on potential outcomes, we prefer its stronger version which can be made a priori. 12

Moreover, Assumption 1 can be tested by using pre-treatment data, while minimal assumptions cannot. Finally, we impose Assumption 1 at the unit level, while sometimes it is imposed on cohortlevel averages. Our approach is in line with the practice of including unit, rather than cohort, FEs in DiD analyses and allows us to avoid biases in incomplete panels where the composition of units changes over time. Moreover, we show in Appendix A.11 that, under random sampling and without compositional changes, assumptions on cohort-level averages imply Assumption 1.

To be able to identify α i and β t , we next rule out anticipation effects, i.e. the causal effects of being treated in the future on current outcomes (e.g. Abbring and Van den Berg, 2003) :

It is straightforward to weaken this assumption, e.g. by allowing anticipation for some k periods before treatment: this simply requires redefining event dates to earlier ones. However, some form of this assumption is necessary for DiD identification, as there would be no reference periods for treated units otherwise. Assumptions 1 and 2 together imply that the observed outcomes Y it for untreated observations follow the TWFE model.

Finally, researchers sometimes impose restrictions on causal effects, explicitly or implicitly. For instance, τ it may be assumed to be homogeneous for all units and periods, or only depend on the number of periods since treatment (but be otherwise homogeneous across units and periods), or perhaps to be time-invariant for each unit. We will consider such restrictions as a possible auxiliary assumption:

Assumption 3 (Restricted causal effects). Bτ = 0 for a known M × N 1 matrix B of full row rank.

It will be more convenient for us to work with an equivalent formulation of Assumption 3, based on N 1 − M free parameters driving treatment effects rather than M restrictions on them:

of the event date. Sant'Anna and Zhao (2020), Arkhangelsky and Imbens (2019) , and Arkhangelsky et al. (2021) consider double-robust estimation of treatment effects in panel data that simultaneously estimates an outcomes model and a propensity-score model. Rambachan and Roth (2020) instead consider a relaxed version of Assumption 1 which imposes bounds on non-parallel trends and leads to set identification of causal effects. Arkhangelsky et al. (2020) relax the parallel-trend assumption in a DiD setting by assuming it only holds relative to a weighted average of control units, where weights can be learned from the data.

12 Specifically, Assumption 4 in Callaway and Sant'Anna (2021) requires that the TWFE model only holds for all treated observations (Dit = 1), observations directly preceding the treatment onset (Kit = −1), and in all periods for never-treated units. Similarly, Goodman-Bacon (2021) proposes to impose parallel trends on a "variance-weighted" average of units, as the weakest assumption under which static OLS estimators we discuss in Section 3 identify some average of causal effects. While technically weaker, this assumption may be hard to justify ex ante without imposing parallel trends on all units as it is unlikely that non-parallel trends will cancel out by averaging. See Section 4.5 for further discussion.

Assumption 3 (Model of causal effects). τ = Γθ, where θ is a (N 1 − M ) × 1 vector of unknown parameters and Γ is a known N 1 × (N 1 − M ) matrix of full column rank.

Assumption 3 imposes a parametric model of treatment effects. For example, the assumption that treatment effects all be the same, τ it ≡ θ 1 , corresponds to N 1 − M = 1 and Γ = (1, . . . , 1) .

Conversely, a "null model" τ it ≡ θ it that imposes no restrictions is captured by M = 0 and Γ = I N 1 .

If restrictions on the treatment effects are implied by economic theory, imposing them will increase estimation power. 13 Often, however, such restrictions are implicitly imposed without an ex ante justification, but just because they yield a simple model for the outcome. We will show in Section 3 how estimators that rely on this assumption can fail to estimate reasonable averages of treatment effects, let alone the specific estimand τ w , when the assumption is violated. We therefore view the null Assumption 3 as a conservative default. We note, however, that this makes the assumptions inherently asymmetric in that they impose restrictive models on potential control outcomes Y it (0) (Assumption 1) but not on treatment effects τ it . This asymmetry reflects the standard practice in staggered rollout DiD designs and is natural when the structure of treatment effects is ex ante unknown, while our framework also accommodates the case where the researcher is willing to impose such structure.

In this section, we first present the ordinary least squares (OLS) regressions with two-way fixed effects that have traditionally been used in DiD designs. We then discuss several estimation challenges that are unaddressed in these specifications, including underidentification of dynamic causal effects, negative weighting, and spurious identification of long-run causal effects. We conclude the section by discussing how our framework also relates to other problems that have been pointed out by Roth (2019) and Sun and Abraham (2021).

Causal effects in staggered adoption DiD designs have traditionally been estimated via Ordinary Least Squares (OLS) regressions with two-way fixed effects. While details may vary, the following specification covers many studies:

Hereα i andβ t are the unit and period ("two-way") fixed effects, a ≥ 0 and b ≥ 0 are the numbers of included "leads" and "lags" of the event indicator, respectively, andε it is the error term. The first lead, 1 [K it = −1], is often excluded as a normalization, while the coefficients on the other leads (if 13 In some cases τw may even not be identified without such restrictions, while it is identified with them. present) are interpreted as measures of "pre-trends," and the hypothesis that τ −a = · · · = τ −2 = 0 is tested visually or statistically. Conditionally on this test passing, the coefficients on the lags are interpreted as a dynamic path of causal effects: at h = 0, . . . , b − 1 periods after treatment and, in the case of τ b+ , at longer horizons binned together. 14 We will refer to this specification as "dynamic"

(as long as a + b > 0) and, more specifically, "fully-dynamic" if it includes all available leads and lags except h = −1, or "semi-dynamic" if it includes all lags but no leads.

Viewed through the lens of the Section 2 framework, these specifications make implicit assumptions on untreated potential outcomes, anticipation and treatment effects, and the estimand of interest. First, they make Assumption 1 but, for a > 0, do not fully impose Assumption 2, allowing for anticipation effects for a periods before treatment. 15 Typically this is done as a means to test Assumption 2 rather than to relax it, but the resulting specification is the same.

Second, Equation (2) Finally, dynamic specifications do not explicitly define the estimands τ h as particular averages of heterogeneous causal effects, even though researchers often admit that the effects may indeed vary across observations. Instead, the OLS coefficients for τ h are interpreted as averages of causal effects for horizon h with unspecified weights, which are presumed to be reasonable (e.g., weighted by some treatment variance, as in the case of OLS with saturated controls; Angrist (1998) ).

Besides dynamic specifications, Equation (2) also nests a very common specification used when a researcher is interested in a single parameter summarizing all causal effects. With a = b = 0, we have the "static" specification in which a single treatment indicator is included:

In line with our Section 2 setting, the static equation imposes the parallel trends and no anticipation Assumptions 1 and 2. However, it also makes a particularly strong version of Assumption 3 -that all treatment effects are the same. Moreover, the target estimand is again not written out as an explicit average of potentially heterogeneous causal effects.

In the rest of this section we turn to the challenges associated with OLS estimation of Equations (2) and (3). We explain how these issues result from the conflation of the target estimand, Assumption 2 and Assumption 3, providing a new and unified perspective on the problems of static and dynamic OLS-based methods.

14 Schmidheiny and Siegloch (2020) discuss the issues that arise when the bin 1 [Kit ≥ b] is not included. Other restrictions on coefficients are also sometimes used: Broda and Parker (2014) , for instance, bin groups of four consecutive horizons together, requiring τ0 = · · · = τ3, τ4 = · · · = τ7, etc. (see Section 6.2).

15 One can alternatively view this specification as imposing Assumption 2 but making a weaker Assumption 1 which includes some pre-trends into Yit(0). This difference in interpretation is immaterial for our results. Notes: This figure shows the evolution of outcomes over seven periods for two units (or cohorts), for the illustrative example of Section 3.2. Vertical lines mark the periods in which the two units are first treated.

The first problem pertains to fully-dynamic specifications and arises because a strong enough Assumption 2 is not imposed. We show that those specifications are under-identified if there is no never-treated group:

Proposition 1. If there are no never-treated units, the path of {τ h } h =−1 coefficients is not pointidentified in the fully-dynamic OLS specification. In particular, for any κ ∈ R, the path {τ h + κ (h + 1)} fits the data equally well, with the fixed effect coefficients appropriately modified.

Proof. All proofs are given in Appendix B.

This result can be illustrated with a simple example, which we intentionally make extreme and free from additional effects and noise. Consider Figure 1 , which plots the outcomes for a simulated dataset with two units (which can be understood as cohort averages): one treated early at t = 2 (solid line) and the other one later at t = 4 (dashed line). Both units are observed for periods t = 1, . . . , 7, and the outcomes exhibit linear growth with the same slope of one, but starting from different levels. There are two interpretations of what could cause such dynamics. On one hand, treatment could have no impact on the outcome, in which case the level difference corresponds to the unit FEs, while trends are just a common feature of the environment, formalized by the period FEs.

On the other hand, note that the outcome equals the number of periods since the event for both groups and all time periods: it is zero at the moment of treatment, negative before, and positive after. So a possible interpretation is that the outcome is entirely driven by causal effects of treatment and anticipation of treatment. One cannot hope to distinguish between unrestricted dynamic causal effects and a combination of unit effects and time trends.

Formally, the problem arises because a linear time trend t and a linear term in the cohort E i (subsumed by the unit FEs) can perfectly reproduce a linear term in relative time

Therefore, a complete set of treatment leads and lags, which is equivalent to the FEs of relative time, is collinear with the unit and period FEs. 16

The problem may be important in practice, as statistical packages may resolve this collinearity by dropping an arbitrary unit or period indicator. Some estimates of {τ h } would then be produced, but because of an arbitrary trend in the coefficients they may suggest a violation of parallel trends even when the specification is in fact correct, i.e. Assumptions 1 and 2 hold and there is no heterogeneity of treatment effects for each horizon (Assumption 3).

To break the collinearity problem, stronger restrictions on anticipation effects, and thus on Y it for untreated observations, have to be introduced. One could consider imposing minimal restrictions on the specification that would make it identified. In typical cases, only a linear trend in {τ h } is not identified in the fully dynamic specification, while nonlinear paths cannot be reproduced with unit and period fixed effects. Therefore, just one additional normalization, e.g. τ −a = 0 in addition to τ −1 = 0, breaks multicollinearity. 17 However, minimal identified models rely on ad hoc identification assumptions which are a priori unattractive. For instance, just imposing τ −a = τ −1 = 0 means that anticipation effects are assumed away 1 and a periods before treatment, but not in other pre-periods. This assumption therefore depends on the realized event times. Instead, a systematic approach is to impose the assumptions -some forms of no anticipation effects and parallel trends -that the researcher has an a priori argument for and which motivated the use of DiD to begin with. Such assumptions on anticipation effects give much stronger identification power relative to the unnecessarily flexible specifications, of which the fully-dynamic specification is an extreme example. Importantly, our suggestion to impose identification assumptions at the estimation stage does not mean that those assumptions should not also be tested; we discuss testing in detail in Section 4.4 below. Rather, the separation of estimation and testing makes the identification argument explicit, while stronger-than-minimal assumptions allow for more powerful testing.

We now show how, by imposing Assumption 3 instead of specifying the estimation target, the static TWFE specification does not identify a reasonably-weighted average of heterogeneous treatment effects. The underlying weights may be negative, particularly for the long-run causal effects. 18

16 The mechanics of this issue are essentially the same as in the well-known "age-cohort-time" problem, where the set of units treated at a given time Ei = e can be viewed as a birth cohort and the relative time Kit = t − Ei serves as age.

17 There are some exceptions in which additional collinearity arises, e.g. when treatment is staggered but happens at periodic intervals.

18 Since de Chaisemartin and D'Haultfoeuille (2015) and our earlier draft pointed out this issue, it has been extensively studied. In a special case of complete panels, Strezhnev (2018) and Goodman-Bacon (2021) provide two decompositions of the static regression's estimand, while de Chaisemartin and D'Haultfoeuille (2020) characterize the weights analytically. We complement this discussion by attributing the fundamental cause of the problem to the conflation of target and assumptions delineated in our framework from Section 2 and provide necessary and suffi- 

Notes: This table shows the evolution of expected outcomes over three periods for two units (or cohorts), for the illustrative example of Proposition 3. Without loss of generality, we normalize β 1 = 0.

Although we focus on the static specification here, the same issues arise in various specifications that bin multiple lags together.

First, we note that, if the parallel trends and no anticipation assumptions hold, static OLS identifies some weighted average of treatment effects: 19

Proposition 2. If Assumptions 1 and 2 hold, then the estimand of the static OLS specification in The static OLS estimand, however, cannot be interpreted as a proper weighted average, as some weights can be negative. We illustrate this problem with a simple example:

Proposition 3. Suppose Assumptions 1 and 2 hold and the data consist of two units (or equalsized cohorts), A and B, treated in periods 2 and 3, respectively, both observed in periods t = 1, 2, 3 (as shown in Table 1 ). Then the estimand of the static OLS specification (3) can be expressed as

This example illustrates the severe short-run bias of TWFE OLS: the long-run causal effect, corresponding to the early-treated unit A and the late period 3, enters with a negative weight (−1/2). Thus, the larger the effects are in the long-run, the smaller the coefficient will be.

This problem results from what we call "forbidden comparisons" performed by OLS. Recall that the original idea of DiD estimation is to compare the evolution of outcomes over some time interval for the units which got treated during that interval relative to a reference group of units which didn't, identifying the period FEs. In the Proposition 3 example, such an "admissible" comparison is between units A and B in periods 2 and 1,

). However, panels with staggered treatment timing also lend themselves to a second type of comparisons -which we label cient conditions for the existence of negative weights in complete panels. Early insights into this problem in specific applications can be found in Wolfers (2006) and Meer and West (2016) .

forbidden -in which the reference group has been treated throughout the relevant period. For units in this group, the treatment indicator D it does not change over the relevant period, and so OLS uses them to identify period FEs, too. The comparison between units B and A in periods 3 and 2,

in Proposition 3 is a case in point. While a comparison like this is appropriate and increases efficiency when treatment effects are homogeneous (which OLS was designed for), forbidden comparisons are problematic under treatment effect homogeneity. For instance, sub-

) not only removes the gap in period FEs, β 3 − β 2 , but also deducts the evolution of treatment effects τ A3 − τ A2 , placing a negative weight on τ A3 . OLS leverages comparisons of both types and estimates the treatment

. 20 Fundamentally, this problem arises because OLS estimation imposes very strong restrictions on treatment effect homogeneity, i.e. Assumption 3, instead of acknowledging the heterogeneity and specifying a particular target estimand (or perhaps a class of estimands that the researcher is indifferent between). Such conflation is likely a consequence of the common perception that regression estimators generally recover reasonably-weighted averages of treatment effects. Even if one gets some variance-weighted average instead of the policy-relevant ATT, the benefit of convenience may dominate. This perception is correct in regressions with saturated controls, as shown by the seminal paper of Angrist (1998) . However, it fails in staggered adoption DiD designs where the set of controls (i.e. unit and period FEs) is non-saturated and complex.

With a large number of never-treated units or a large number of periods before any unit is treated (relative to other units and periods), our setting becomes closer to a classical non-staggered DiD design, and therefore negative weights disappear, as our next result illustrates: Even when weights are non-negative, they may remain highly unequal and diverge from the estimands that the researcher is interested in. Our preferred strategy is therefore to commit to the estimation target and explicitly allow for treatment effect heterogeneity, except when some form of Assumption 3 is ex ante appropriate. 20 The proof of Proposition 2 shows why long-run effects in particular are subject to the negative weights problem. In general, negative weights arise for the treated observations, for which the residual from an auxiliary regression of Dit on the two-way FEs is negative. de Chaisemartin and D'Haultfoeuille (2020) show that, in complete panels, the unit FEs are higher for early-treated units (which are observed treated for a larger shares of periods) and period FEs are higher for later periods (in which a larger shares of units are treated). The early-treated units observed in later periods correspond to the long-run effects. 21 N * 1 and N * 0 respectively correspond to the numbers of admissible and forbidden 2x2 DiD comparisons available for the earliest-treated units in the latest period T . The gap between them drives negative weights with complete panels, as in Strezhnev (2018, Proposition 1).

Another consequence of inappropriately imposing Assumption 3 concerns estimation of long-run causal effects. Dynamic OLS specifications (except those subject to the underidentification problem)

yield some estimates for all τ h coefficients. Yet, for large enough h, no averages of treatment effects are identified under Assumptions 1 and 2 with unrestricted treatment effect heterogeneity. Therefore, OLS estimates are fully driven by unwarranted extrapolation of treatment effects across observations and may not be reliable, unless strong ex ante reasons for Assumption 3 exist.

This issue is well illustrated in the example of Proposition 3. To identify the long-run effect τ A3 under Assumptions 1 and 2, one needs to form an admissible DiD comparison, of the outcome growth over some period between unit A and another unit not yet treated in period 3. However, by period 3 both units have been treated. Mechanically, this problem arises because the period fixed effect β 3 is not identified separately from the treatment effects τ A3 and τ B3 in this example, absent restrictions on treatment effects. Yet, the semi-dynamic OLS specification

will produce an estimateτ 1 via extrapolation. Specifically, two different parameters, τ A3 − τ B3

and τ A2 , are identified by comparing the two units in periods 2 or 3, respectively, with period 1.

Therefore, OLS that imposes the homogeneity of short-run effects across units, τ A2 = τ B3 ≡ τ 0 , estimates the long-run effect τ A3 ≡ τ 1 as the sum of τ 1 − τ 0 and τ 0 :

However, when τ A2 = τ B3 , this estimator is biased.

In general, the gap between the earliest and the latest event times observed in the data puts an upper bound on the number of dynamic coefficients that can be identified without extrapolation of treatment effects. This result, which follows by the same logic of non-identification of the later period effects, is formalized by our next proposition:

Proposition 5. Suppose there are no never-treated units and letH = max i E i − min i E i . Then, for any non-negative weights w it defined over the set of observations with K it ≥H (that are not identically zero), the weighted sum of causal effects it : K it ≥H w it τ it is not identified by Assumptions 1 and 2. 22

This result applies to all estimators, not just those based on OLS. However, robust estimators, including the one we characterize in Section 4, would not be possible to compute for non-identified estimands, never resulting in spurious estimates. 22 The requirement that the weights are non-negative rules out some estimands on the gaps between treatment effects for Kit ≥H which are in fact identified. For instance, adding period t = 4 to the Table 1 example, the difference τA4 − τB4 would be identified (by (YA4 − YB4) − (YA1 − YB1)), even though neither τA4 nor τB4 is.

We finally discuss three limitations of conventional practice pointed out in other work. We use our framework to connect these issues to the conflation of assumptions about treatment effect heterogeneity and the Section 2 assumptions.

First, Roth (2019) uncovers undesirable consequences of conditioning on a pre-trend test passing. He shows that OLS pre-trend estimates are correlated with the estimates of treatment effects obtained from the same dynamic specification. As a consequence, when Assumptions 1 and 2 are satisfied, pre-trend testing makes statistical inference on the coefficients invalid; if the assumptions are instead violated, this can exacerbate estimation bias. In Section 4.4 we will show that this problem can be attributed to the fact that Assumption 2 is not imposed when estimating the treatment effects by dynamic OLS specifications, and testing is not separated from estimation-similarly to the underidentification problem discussed above.

Second, Sun and Abraham (2021) show that the negative weighting problem from Section 3.3 is also relevant in dynamic OLS specifications. Specifically, causal estimates for one horizon may be confounded by heterogeneous effects across treatment cohorts at other horizons. 23 This may not be surprising given that long-run effects are not identified absent Assumption 3, and thus dynamic OLS coefficients have to be based on extrapolations of treatment effects. In light of our framework, this problem arises because Assumption 3 is imposed instead of specifying a target estimand.

Finally, Sun and Abraham (2021) further show that conventional pre-trend tests may reject Assumption 2 when the assumption is satisfied or pass when the assumption fails, all because of heterogeneous treatment effects. That problem is another variation on how the Section 2 assumptions may be conflated: the conventional pre-trend test for Assumptions 1 and 2 is in fact a joint test of those assumptions together with implicit Assumption 3 and can reject because of the latter.

We finally point out that the challenges above apply even if the sample is "trimmed" to a fixed window around the event time. By trimming, we mean the relatively common practice (sometimes also referred to as "balancing") of dropping observations more than a periods before or b periods after the event, for some a > 0 and b ≥ 0 (e.g. Miller (2017) , Bartik and Nelson (2021) ).

One may think that the static and dynamic TWFE OLS estimands may be close to their desirable targets in trimmed samples because by construction the composition of units is unchanged across horizons (i.e., across all leads and lags of the event). However, we show that, with staggered adoption, the weights implied by TWFE regressions can remain complex and highly skewed. Intuitively, this follows because trimmed panels are necessarily unbalanced in terms of units and periods; for instance, the composition of units varies across periods by construction. 24 Perhaps surprisingly, OLS estimands can even have worse properties in trimmed samples.

To illustrate how the challenges of OLS persist with trimming -and can be made worse -in Appendix A.1 we present a numerical example. In the example, negative weighting in the static TWFE OLS regression is even more severe after trimming. Similarly, weights implied by the dynamic specification with trimming show an even larger skew than without trimming. Finally, trimming can exacerbate the issue of spurious identification of long-run effects. Since trimming also generally reduces the sample size and thus estimation efficiency, it appears difficult to justify. 25

In sum, Section 3 has shown that OLS estimation of both static and dynamic TWFE specifications suffers from a host of challenges, which all arise from the conflation of the target estimand and Assumptions 1, 2 and 3. Importantly, these problems pertain only to OLS estimation of event studies, not to the event study design itself, as we show next.

To overcome the challenges of conventional practice we now derive the robust and efficient estimator and show that it takes a particularly transparent "imputation" form when no restrictions on treatment-effect heterogeneity are imposed. We then perform asymptotic analysis, establishing the conditions for the estimator to be consistent and asymptotically Normal, deriving conservative standard error estimates for it, and discussing appropriate pre-trend tests. Next, we compare the imputation estimator with other methods recently proposed in response to some problems with OLS estimation. We conclude the section by providing simulation evidence that the efficiency gains from using our estimator are sizable, that its sensitivity to some parallel trend violations is no larger than that of the alternatives, and that our inference tools perform well in finite samples.

Our theoretical results apply in a class of models more general than those that satisfy Assumption 1. We therefore relax it to have:

a vector of unit-specific nuisance parameters, δ is a vector of nuisance parameters associated with common covariates, and A it and X it are known non-stochastic vectors.

The first term in this model of Y it (0) nests unit FEs, but also allows to interact them with some observed covariates unaffected by the treatment status, e.g. to include unit-specific trends. 26

The second term nests period FEs but additionally allows any time-varying covariates, i.e. X it δ = β t +X itδ (again, for the covariates unaffected by the treatment). We note that Assumption 1 looks similar to a factor model, but differs crucially in that regressors A it are observed.

would make the OLS estimand closer to its desirable target. In fact, in the presence of period FEs (and residualizing on them), unit indicators are no longer orthogonal to the lag and lead indicators in trimmed samples. Thus, regressions without unit FEs do not estimate weighted sums of treatment effects under Assumptions 1 and 2. 25 One scenario in which trimming is justified within our framework is when Assumptions 1 and 2 are imposed only on observations within a certain window of the event.

26 Without further restrictions on X it δ, there is redundancy in this formulation. However, we will impose such restrictions when considering the asymptotic behavior of the estimator below. We note that Assumption 1 also nests specifications that exclude unit or period FEs.

As previously, we suppose that a researcher has chosen estimation target τ w and made Assumption 2. Some model of treatment effects (Assumption 3) is also assumed, although our main focus is on the null model, under which treatment effect heterogeneity is unrestricted. Letting

for it ∈ Ω, we thus have under Assumptions 1 , 2 and 3 :

We assume throughout that the treatment-effect parameters θ are identified. 27

For our efficiency result we impose an additional homoskedasticity assumption:

Assumption 4 (Homoskedastic errors). Error terms ε it are homoskedastic and mutually uncorre-

While this assumption is strong, our efficiency results also apply without change under dependence that is due to unit random effects, i.e. if ε it = η i +ε it forε it that satisfy Assumption 4 and for some η i . Moreover, these results are straightforward to relax to any known form of heteroskedasticity or mutual dependence. 28 Under Assumption 4 and allowing for restrictions on causal effects, we have:

Theorem 1 (Efficient estimator). Suppose Assumptions 1 , 2, 3 and 4 hold. Then among the linear unbiased estimators of τ w , the (unique) efficient estimatorτ * w can be obtained with the following steps:

1. Estimate θ by the OLS solutionθ * from the linear regression (4) (where we assume that θ is identified); 2. Estimate the vector of treatment effects τ byτ * = Γθ * ;

3. Estimate the target τ w byτ * w = w 1τ * .

Moreover, this estimatorτ * w is unbiased for τ w under Assumptions 1 , 2 and 3 alone, even when error terms are not homoskedastic.

Under Assumptions 1 , 2 and 3 , regression (4) is correctly specified. Thus, this estimator for θ is unbiased by construction, and efficiency under homoskedasticity of error terms is a direct consequence of the Gauss-Markov theorem. Moreover, OLS yields the most efficient estimator for any linear 27 In order to estimate θ, we do not necessarily need to identify all fixed effects in Yit(0) separately; it is sufficient that the fitted values E [Yit(0)] = A it λi +X it δ are identified. For example, we could shift all unit FEs up and all period FEs down by the same constant, but this change is immaterial for the fitted values. Practically, we can ensure that all parameters are uniquely identified by restricting some of them. For example, in the baseline case of two-way fixed effects we can set the FE of either one unit or one period to zero, since the model is otherwise over-parameterized. 28 For instance, if error terms are uncorrelated and have known variances σ 2 it (up to a scaling factor), efficiency requires the estimation step (Step 1) of Theorems 1 and 2 to be performed with weights proportional to σ −2 it . One example for this is when the data are aggregated from nit individuals randomly drawn from group i in period t and homoskedastic individual-level errors, in which case efficiency is obtained with weights proportional to nit. combination of θ, including τ w = w 1 Γθ. While assuming homoskedasticity may be unrealistic in practice, we think of this assumption as a natural benchmark to decide between the many unbiased estimators of τ w . Theorem 1 also assumes that the parameter vector θ is identified in the regression model in (4). This, for instance, rules out estimation of long-run treatment effects (absent strong restrictions on treatment effects), in line with Proposition 5.

In the important special case of unrestricted treatment effect heterogeneity,τ * w has a useful "imputation" representation. The idea is to estimate the model of Y it (0) using the untreated observations it ∈ Ω 0 and leverage it to impute Y it (0) for treated observations it ∈ Ω 1 . Then, observation-specific causal effect estimates can be averaged appropriately. Perhaps surprisingly, the estimation and imputation steps are identical regardless of the target estimand. Applying any weights to the imputed causal effects yields the efficient estimator for the corresponding estimand. We have:

Theorem 2 (Imputation representation for the efficient estimator). With a null Assumption 3 (that is, if Γ = I N 1 ), the unique efficient linear unbiased estimatorτ * w of τ w from Theorem 1 can be obtained via an imputation procedure:

1. Within the untreated observations only (it ∈ Ω 0 ), estimate the λ i and δ (byλ * i ,δ * ) by OLS in the regression

The imputation structure of the estimator is related to the "direct estimation of the counterfactual" form considered by Gobillon and Magnac (2016) for linear factor models. In the special case of two-way fixed effects as Assumption 1 , the estimator from this theorem yields the "counterfactual"

and "two-stage" estimators proposed in independent work by Liu et al. (2020) and Gardner (2021) for the specific choices of the weights w 1 they consider, and can in this case also be understood as a matrix-completion estimator in the framework of Athey et al. (2021) without a factor model or regularization. Here, we derive a general imputation estimator for arbitrary estimands as the unique efficient linear estimator in our setting.

The imputation representation offers computational and conceptual benefits. First, it is computationally efficient as it only requires estimating a simple TWFE model, for which fast algorithms are available (Guimarães and Portugal, 2010; Correia, 2017) . This is in contrast to the OLS estimator from Theorem 1, as Equation (4) has regressors Γ it D it in addition to the fixed effects, which are high-dimensional unless a low-dimensional model of treatment effect heterogeneity is imposed.

Second, the imputation approach is intuitive and transparently links the parallel trends and no anticipation assumptions to the estimator. Indeed, Imbens and Rubin (2015) write: "At some level, all methods for causal inference can be viewed as imputation methods, although some more explicitly than others" (p. 141). We formalize this statement in the next proposition, which shows that any estimator unbiased for τ w can be represented in the imputation way, but the way of imputing the Y it (0) may be less explicit and no longer efficient.

Proposition 6 (Imputation representation for all unbiased estimators). Under Assumptions 1 and 2, any linear estimatorτ w of τ w that is unbiased under arbitrary treatment-effect heterogeneity (that is, a null Assumption 3) can be obtained via imputation:

1. For every treated observation, estimate expected untreated potential outcomes A it λ i + X it δ by some unbiased linear estimatorŶ it (0) using data from the untreated observations only;

3. Estimate the target by a weighted sumτ w = it∈Ω 1 w itτit .

This result establishes an imputation representation when treatment effects can vary arbitrarily. Proposition A1 in the appendix establishes that the imputation structure applies even when restrictions τ = Γθ are imposed, albeit with an additional step in which the weights w 1 defining the estimand are adjusted in a way that does not change τ w under the imposed model. 29 In this sense, unbiased causal inference is equivalent to imputation in our framework.

Having derived the linear unbiased estimatorτ * w for τ w in Theorem 1 that is also efficient under homoskedastic errors terms, we now consider its asymptotic properties without imposing homoskedasticity. We study convergence along a sequence of panels indexed by the sample size N , where randomness stems from the error terms ε it only, as in Section 2. Our approach applies to asymptotic sequences where both the number of units and the number of time periods may grow, but the assumptions are least restrictive when the number of time periods remains constant or grows slowly, as in short panels. By viewing the set of observations Ω, treatment timing, and all FEs and controls as non-stochastic, we do not have to impose assumptions on the sampling of the weights w 1 themselves, but can take them as given.

Instead of making Assumption 4, that error terms are homoskedastic and uncorrelated, we now only assume that error terms are clustered by units i.

Assumption 5 (Clustered error terms). Error terms ε it are uncorrelated across units and have bounded variance: Cov [ε it , ε js ] = 0 for i = j and it, js ∈ Ω, and Var [ε it ] ≤σ 2 for it ∈ Ω uniformly.

The key role in our results is played by the weights that the Theorem 1 estimator places on each observation. Since the estimator is linear in the observed outcomes Y it , we can write it aŝ

We now formulate high-level conditions on the sequence of weight vectors that ensure consistency, asymptotic Normality, and will later allow us to provide valid inference. These results apply to any unbiased linear estimatorτ w = it∈Ω v it Y it of τ w , not just the efficient estimatorτ * w from Theorem 1 -that is, if the respective conditions are fulfilled for the weights v it , then consistency, asymptotic Normality, and valid inference follow as stated. For the specific estimatorτ * w introduced above, we then provide sufficient low-level conditions for short panels.

First, we obtain consistency ofτ w under a Herfindahl condition on the weights v that takes the clustering structure of error terms into account.

Assumption 6 (Herfindahl condition). Along the asymptotic sequence,

The condition on the clustered Herfindahl index v 2 H states that the sum of squared weights vanishes, where weights are aggregated by units. One can think of the inverse of the sum of squared weights, n H = v −2 H , as a measure of effective sample size, which Assumption 6 requires to grow large along the asymptotic sequence. If it is satisfied, and variances are uniformly bounded, then the difference between the estimatorτ w and the estimand τ w vanishes asymptotically, and we obtain consistency:

Proposition 7 (Consistency ofτ w ). Under Assumptions 1 , 2, 3 , 5 and 6,τ w − τ w L 2 → 0 for an unbiased estimatorτ w of τ w , such asτ * w in Theorem 1. 30 We next consider the asymptotic distribution of the estimator around the estimand.

Proposition 8 (Asymptotic Normality). Under the assumptions of Proposition 7, a balance assumption on higher moments of the weights (Assumption A1), and if lim inf n H σ 2 w > 0 for σ 2 w = Var [τ w ], we have that

This result establishes conditions under which the difference between estimator and estimand is asymptotically Normal. Besides regularity, this proposition requires that the estimator variance σ 2 w does not decline faster than 1/n H . It is violated if the clustered Herfindahl formula is too conservative: for instance, if the number of periods is growing along the asymptotic sequence while the within-unit over-time correlation of error terms remains small. Alternative sufficient conditions for asymptotic Normality can be established in such cases, e.g. along the lines of Footnote 30. 30 The Herfindahl condition can be restrictive since it allows for a worst-case correlation of error terms within units. When such correlations are limited, other sufficient conditions may be more appropriate instead, such as

Here R is a measure of the maximal joint covariation of all observations for one unit. If error terms are uncorrelated, then R ≤ 1, since the maximal eigenvalue of Σi corresponds to the maximal variance of an error term εit in this case, which is bounded byσ 2 . An upper bound for R is the maximal number of periods for which we observe a unit, since the maximal eigenvalue of Σi is bounded by the sum of the variances on its diagonal.

So far, we have formulated high-level conditions on the weights v it of any linear unbiased estimator of τ w . Appendix A.4 presents low-level sufficient conditions for consistency and asymptotic Normality of the imputation estimatorτ * w for the benchmark case of a panel with unit and period fixed effects, a fixed or slowly growing number of periods, and no restrictions on treatment effects. Unlike Propositions 7 and 8, these conditions are imposed directly on the weights w 1 chosen by the researcher, and not on the the implied weights v * it , and are therefore easy to verify. In particular, the estimator achieves consistency and asymptotic Normality in the common case where the number of time periods is fixed, the size of all cohorts increases, the weights on treatment effects do not vary within the same period and cohort, and the sum of (absolute) weights is bounded. In addition, the sufficient conditions are also fulfilled when the number of periods grows slowly and when weights differ across observations within the same cohort and period, but not by too much.

Our goal next is to estimate the variance ofτ w = it∈Ω v it Y it , which equals

with clustered error terms (Assumption 5). We start with the case where treatment effect heterogeneity is unrestricted (i.e. Γ = I). As in Section 4.2, the inference tools we propose apply to a generic linear unbiased estimator but we use them for the efficient estimatorτ * w . Our strategy is to estimate individual error terms by someε it and then use a plug-in estimator,

Estimating the error terms presents two challenges, which become apparent when we consider

it in the regression (4). The first challenge is that the fixed effects λ i are not generally estimated consistently (e.g., in short panels). This inconsistency, however, turns out to be inconsequential because the candidate variance estimator i t;it∈Ω v itεit 2 is numerically invariant to the underlyingλ * i estimates. This invariance property ofσ 2 w derives from the invariance ofτ * w to adding arbitrary unit fixed effects (or, more generally, A iλ i terms for some i andλ i ) to the outcomes; this was earlier pointed out by Stock and Watson (2008) .

A second challenge arises from unrestricted treatment-effect heterogeneity. In Theorem 2, treatment effects are estimated by fitting the corresponding outcomes Y it perfectly, with residualsε it ≡ 0 for all treated observations. This issue is not specific to our estimation procedure: one generally cannot distinguish between τ it and ε it from observations of Y it = A i λ i + X it δ + τ it + ε it for treated observations, making it impossible to produce unbiased estimates of σ 2 w (see Lemma 1 in Kline et al. (2020) for a similar impossibility result).

While unbiased estimation of σ 2 w is not possible, we show that this variance can be estimated conservatively. Our variance estimator is based on an auxiliary parsimonious model of treatment effects. We do not require this model to be correct, in the sense that inference is weakly asymptotically conservative under misspecification. However, auxiliary models which better approximate τ it will make confidence intervals tighter and closer to asymptotically exact. In the computation of σ 2 w we setε it for the treated observations equal to the residuals of the auxiliary model. We require the model to be parsimonious, such that it does not overfit and the residuals include ε it . When the model is incorrect,ε it also include a component due to the misspecification of τ it , leading to conservative inference.

We formalize the auxiliary model by considering estimatorsτ it for each it ∈ Ω 1 which satisfy two properties: (1)τ it converges to some non-stochastic limitτ it and (2) if the auxiliary model is correct,τ it = τ it . The following theorem presents conditions applicable to short panels under which our construction yields asymptotically conservative inference:

Theorem 3 (Conservative clustered standard error estimates). Assume that the assumptions of Proposition 7 hold, that the model of treatment effects is trivial (Γ = I), that the estimatesτ it converge to some non-randomτ it in the sense that v −2

from Theorem 1 is sufficiently close to δ in the sense of a mean-squared error of weighted fitted values (Assumption A2), and that additional regularity conditions on the moments of the model parameters and weights hold (Assumption A3). Then the variance estimatê

is asymptotically conservative:

It remains to be discussed how to choose the estimatesτ it . We focus on auxiliary models that impose the equality of treatment effects across large groups of treated observations: for a partition

The τ g can then be estimated by some weighted average ofτ * it among it ∈ G g . Specifically, we propose averages of the form

In the appendix, we show that this choice of weights leads to minimal excess variance σ 2 τ in the case where there is only a single group g. The corresponds to a conservative auxiliary model which requires all treatment effects to be the same. In general, the choice of the partition aims to maintain a balance between avoiding overly conservative variance estimates and ensuring consistency. If the sample is large enough, one may want to partition Ω 1 into multiple groups of observations such that treatment effect heterogeneity is expected to be smaller within them than across. For instance, with many units, a group may consist of observations corresponding to the same horizon relative to treatment onset. If cohorts are large, one can further partition observations into groups defined by cohort and period.

While sufficiently large groups in (8) avoid overfitting asymptotically (under appropriate conditions), in finite samples theseτ it still useτ * it and thus partially overfit to ε it . In Appendix A.6 we therefore also consider leave-out versions of leave-out versions of theseτ it .

We make four final remarks on Theorem 3. First, our strategy for estimating the variance extends directly to conservative estimation of variance-covariance matrices for vector-valued estimands, e.g.

for average treatment effects at multiple horizons h. Second, the result applies in short panels under the low-level conditions of Appendix A.4 (see Proposition A6). Third, while we have focused here on the case of unrestricted heterogeneity (Γ = I), Theorem 3 can be extended to the case with a non-trivial treatment-effect model imposed in Assumption 3. 31 Finally, computation ofσ 2 w for the estimatorτ * w from Theorem 1 involves the implied weights v * it , which becomes computationally challenging with multiple sets of high-dimensional FEs. In Appendix A.7 we develop a computationally efficient algorithm for computing v * it based on the iterative least squares algorithm for conventional regression coefficients (Guimarães and Portugal, 2010) .

Above, we have considered efficient estimation of weighted average treatment effects in event studies when the parallel-trend and no-anticipation assumptions hold. In this section, we discuss testing these assumptions. Specifically, we now propose a principled way to falsify parallel trends with no anticipatory effects or, more generally, Assumptions 1 and 2. Our testing procedure is based on OLS regressions with untreated observations only, departing from both traditional regression-based tests and more recent placebo tests. This procedure is robust to treatment effect heterogeneity and, under homoskedasticity, has attractive power properties and avoids the pre-testing problem explained by Roth (2019) . We propose:

1. Choose an alternative model for Y it for untreated observations it ∈ Ω 0 that is richer than that imposed by Assumptions 1 and 2: for an observable vector W it ,

2. Estimate γ byγ in (9) using OLS on untreated observations only;

31 By Proposition A1, the general efficient estimator can be represented as an imputation estimator for a modified estimand, i.e. by changing w1 to some v1. Theorem 3 then yields a conservative variance estimate for it. We note that under sufficiently strong restrictions on treatment effects, asymptotically exact inference may be possible, as the residualsεit in (4) may be estimated consistently even for treated observations (except for the inconsequential noise inλi), alleviating the need for an additional auxiliary model.

This test is valid because equation (9) is implied by Assumptions 1 and 2 if and only if the null

The test requires choosing W it , parameterizing the possible violation of Assumptions 1 and 2.

A natural choice for W it , which parallels conventional pre-trend tests, is a set of indicators for observations 1, . . . , k periods before the onset of treatment for some k, 32 with periods before E i − k serving as the reference group. This choice is appropriate, for instance, if the researcher's main worry is the possible effects of treatment anticipation, i.e. violations of Assumption 2. 33 This choice of W it also lends itself to making "event study plots," which combine the ATT estimates by horizon h ≥ 0 with a series of pre-trend coefficients; we supply the event_plot Stata command for this goal. 34

Test 1 possesses well-known efficiency properties when W it is correctly specified: e.g., it is uniformly most powerful invariant test whenε it are homoskedastic and normal (Lehmann and Romano, 2006, Ch. 7.6 ). Yet, even if the true violation of Assumptions 1 and 2 is not fully captured by the chosen W it , the test will still be powerful against many, although not all, alternatives.

Test 1 can be contrasted with two existing strategies to test parallel trends. Traditionally, researchers estimated a dynamic specification which includes both lags and leads of treatment onset, and tested -visually or statistically -that the coefficients on leads are equal to zero. More recent papers (e.g. de Chaisemartin and D'Haultfoeuille, 2020; Liu et al., 2020) replace it with a placebo strategy: pretend that treatment happened k periods earlier for all eventually treated units, and estimate the average effects h = 0, . . . , k − 1 periods after the placebo treatment using the same estimator as for actual estimation. Our imputation estimator can be used with that approach, too, similar to Liu et al. (2020) . 35

Both of these alternatives strategies have drawbacks. Because the traditional regression-based test uses the full sample, including treated observations, it is not a test for Assumptions 1 and 2 only. Rather, it is a joint test that is also sensitive to violations of the implicit Assumption 3: that treatment effects τ it for it ∈ Ω 1 are homogeneous within each horizon (Sun and Abraham, 2021).

Even if a researcher has reasons to impose a non-trivial Assumption 3 in estimation, a robust test for parallel trends and no anticipation per se should avoid those restrictions on treatment effect heterogeneity.With a null Assumption 3, treated observations are not useful for testing, and our test 32 The optimal choice of k is a challenging question that we leave to future research. As usual with F -tests, choosing a k that is too large can lead to low power against many alternatives, in particular those that generate large biases in treatment effect estimates that impose invalid Assumption 1 .

33 Alternatively, the researcher may focus on possible violations of the parametric structure in Assumption 1 . For instance, with data spanning many years one could test for the presence of a structural break, e.g. that αi are the same before and after the Great Recession (up to a constant shift captured by the period FEs).

34 Since our estimation and testing procedures are (intentionally) different, event_plot shows the two sets of coefficients in different colors by default. 35 Liu et al. (2020) propose two tests of pre-trends based on an imputation strategy. First, they propose a placebo test that re-runs their robust estimator with earlier, counterfactual treatment times. Second, they consider an F -test based on pre-treatment data only, based on averages of outcome residuals from the imputation stage for each horizon before treatment. In contrast, Test 1 models and estimates a potential alternative explicitly to ensure efficiency for detecting these specific violations.

only uses the untreated ones.

Tests based on placebo estimates appropriately use untreated observations only, but they suffer from a conceptual problem that may result in a power loss. The problem arises because the placebo strategy does not make a distinction between estimation and testing, and specifies a precise placebo estimation target -typically the placebo ATT. However, according to the standard logic of statistical assumption testing, the choice of the test should be based on a guess about the class of most plausible alternatives, while mimicking the estimator does not generally correspond to an efficient test of any such class.

We now show an additional advantage of Test 1: if the researcher conditions on the test passing (i.e. does not report the results otherwise), inference onτ * w is still asymptotically valid under the null of no violations of Assumptions 1 and 2 and under homoskedasticity. This stands in contrast with the results by Roth (2019) who find distorted inference in the context of dynamic event study OLS regressions.

Proposition 9 (Pre-test robustness). Suppose Assumptions 1 , 2 and 4 hold. Considerτ * w constructed as in Theorem 1 for some estimation target and with some Γ. Thenτ * w is uncorrelated with any vectorγ constructed as in Test 1. Consequently, if the vector (τ * w ,γ) is asymptotically Normal, τ * w andγ are asymptotically independent, and conditioning onγ ∈ R γ for a non-stochastic rejection region R γ does not asymptotically affect the distribution ofτ * w . 36

Key to this proposition is the separation of estimation and testing: estimation imposes Assumptions 1 and 2, while testing uses untreated observations only, which are not confounded by treatment effects. The formal logic behind it is similar to that of Hausman tests: under Assumptions 1 , 2 and 4 and additionally imposing appropriate Assumption 3,τ * w is efficient for τ w . Under the same assumptions,γ is unbiased for zero and thus should be uncorrelated withτ * w , or elseτ * w + ζ γ would be more efficient for some ζ.

While we use Proposition 9 for the efficient estimators from Theorem 1, we note that it applies well beyond. This is because it does not require that Assumption 3 used to constructτ * w (via Γ) actually holds. Thus, the result applies, for instance, to the static TWFE estimator which is a special case of Theorem 1 with all treatment effects assumed (perhaps incorrectly) to be the same.

Similarly, it applies to dynamic OLS specifications that include only lags of the event and no leads. 37

In contrast, Proposition 9 fails when estimation and testing are done simultaneously. This point is most simply illustrated in conventional DiD designs where treatment happens at the same time in the treatment group and never in the control group. Then the period right before treatment is used as the sole reference period for both the estimates and the test statistics with a fully-dynamic regression, creating a correlation between them and leading to the pre-testing bias. 36 An early version of Roth (2019) shows how to construct an adjustment that removes the dependence when it exists, provided the covariance matrix betweenτ * andγ can be estimated. By Proposition 9, this adjustment is not needed for the Theorem 1 estimator under homoskedasticity.

37 Furthermore, Proposition 9 also holds when testing is done with the placebo imputation estimator, rather than by OLS as we suggested above. This is because placebo treatment effects γit can be recovered from (9), by stacking the dummies for all individual observations up to k periods before treatment into Wit. Thus, the placebo test is a special case of Test 1, except withγit averaged for each horizon before applying the F -test.

Since the problems of OLS event study regressions were first discussed, several alternative approaches robust to treatment effect heterogeneity have been developed. We now analyze these proposals through the lens of our framework and contrast our efficient imputation estimator with strategies based on manual aggregation of admissible DiD comparisons, focusing on the case where treatmenteffect heterogeneity is not constrained (Γ = I). We also connect our imputation strategy to a related idea proposed for factor models.

de Chaisemartin and D'Haultfoeuille (2021), Sun and Abraham (2021) and Callaway and Sant'Anna (2021) develop alternative estimators that are robust to arbitrary treatment effect heterogeneity. In the first step, they estimate "cohort-average treatment effects" CAT T e,t , i.e. ATTs for all units first treated in e and observed at t ≥ e. Specifically, they propose (different) explicit formulas that leverage DiD comparisons for the cohort e in period t against some reference set of cohorts (e.g. never-treated or not-yet-treated by t) and against period e − 1, which directly precedes treatment.

The CAT T e,t estimates are then appropriately aggregated across cohorts and periods. 38

The key advantage of the imputation estimator is that it imputes the untreated potential outcomes Y it (0) for treated observations it ∈ Ω 1 from the full set of untreated observations, yielding the efficiency properties formalized by Theorem 2. By Proposition 6, these alternative estimators, which are linear and robust, can also be viewed as relying on some estimates of Y it (0). However, those estimates are not the efficient choices under Assumptions 1, 2 and 4 since they only use data from period e − 1 for CAT T e,t ; the reference group is also restricted by some of them. 39 Although our imputation estimator is only most efficient under homoskedasticity, the use of all available data should make it more efficient with many heteroskedasticity and mutual correlation structures, as we find in the simulation in Section 4.6 and in the application in Section 6.3.

In principle, there could be a trade-off between efficiency and robustness, if other estimators were valid under weaker identification assumptions. While de Chaisemartin and D'Haultfoeuille (2021) and Sun and Abraham (2021) impose parallel trends and no anticipation assumptions equivalent to ours, the assumptions in Callaway and Sant'Anna (2021) may appear weaker: they require outcome trends to be parallel between treated unit i and some reference group only since period E i − 1 but not before. However, in the important case where all not-yet-treated cohorts are used as reference group, the trends in untreated potential outcomes of those cohorts are implicitly assumed to be parallel (Marcus and Sant'Anna, 2020) , bridging the gap between assumptions. 40 Therefore, more 38 Fadlon and Nielsen (2015) propose a similar approach based on matching treated and not-yet-treated units, while Cengiz et al. (2019) develop a related "stacked regressions" approach.

39 Indeed, the equivalent versions of the Sun and Abraham (2021) and Callaway and Sant'Anna (2021) estimators of the horizon-specific ATT (and without additional covariates) that rely on never-treated units as their reference group are the same as the imputation estimator after dropping all observations of ever-treated units i before period Ei − 1.

40 More precisely, the results of Marcus and Sant'Anna (2020) imply that Assumption 5 in Callaway and Sant'Anna (2021) is equivalent to our Assumption 1 when there are no extra covariates and when some units are treated at t = 2, such that Ei − 1 for them is the earliest period observed in the data. Appendix A.8 provides an illustrative example of how the imputation estimator achieves efficiency gains in that case. When mini Ei > 2, the assumptions diverge. However, while a researcher may have a priori reasons to think that some older periods should not be used (e.g. because of a structural break), we prefer to make any assumption on potential outcomes ex ante and not based efficient imputation of Y it (0) in Theorem 2 is not just a consequence of stronger assumptions.

The efficient imputation estimator offers four additional benefits over the alternatives discussed above. First, by transparently mapping the model of Y it (0) into the estimator, it is immediately extended to models richer than TWFE, such as with unit-specific trends or in triple-difference strategies, with the same efficiency properties (see Section 5). Second, by separating testing of parallel trends from estimation, it mitigates the pre-testing problem of Roth (2019), as we have shown in Section 4.4. This is in contrast to estimators which use the same reference period, from E i −1 to E i , for both estimation and testing (e.g. de Chaisemartin and D'Haultfoeuille, 2021; Sun and Abraham, 2021) , generating a correlation between the resulting coefficients. Third, since our framework does not require random sampling, we allow for a more general class of estimands. Specifically, any weighted sum of treated observations is allowed for, e.g. the difference between the average effects Our imputation approach is closely related to the "direct estimation of the counterfactual" approach proposed by Gobillon and Magnac (2016) in a different context, for linear factor models.

Like in Theorem 2, they estimate the model of Y it (0) -albeit a different model -on untreated observations only and extrapolate it to the treated observations. Xu (2017) notes the applicability of this approach in DiD settings too. A follow-up paper by Liu et al. (2020) further develops the counterfactual estimation approach for staggered rollout DiD, and Gardner (2021) similarly proposes a "two-stage DiD estimator" based on a specification with cohort and period FEs. Both the Liu et al. (2020) and Gardner (2021) estimators, developed independently from our work, coincide with the imputation estimator for the estimands they consider: the overall ATT and the average effect a given number of periods after treatment. For the overall ATT, the imputation estimator is also a matrix-completion estimator without a factor model or regularization in the class considered by Athey et al. (2021) . Compared with these studies, we derive the imputation estimator as the most efficient one for a class of problems and a general class of target estimands, allow for restrictions on treatment effects, and consider a series of extensions. Moreover, we develop asymptotic theory for the estimator and provide analytical standard errors for the standard case when fixed effects are on the individual level. 42 on the realized period Ei of first treatment. 41 Our standard errors are only conservative, while the analytical standard errors of Sun and Abraham (2021) are asymptotically exact. However, this difference arises because we consider a sample estimand in a fixed sample, while Sun and Abraham (2021) consider a population estimand in a sampling framework. In the case where the estimand is based on cohort average treatment effects (withτit similarly specified) and deviations from these averages are seen as realizations of mean-zero random variables (as would be the case for random sampling), our standard errors are asymptotically exact, too. 42 Gardner (2021) derives large-sample theory by interpreting the estimator as a GMM estimator with cohort FEs,

We now quantify the efficiency properties of the imputation estimator in a simulated dataset, both under homoskedastic, serially uncorrelated error terms and without those assumptions, in comparison to the alternative robust estimators of de Chaisemartin and D'Haultfoeuille (2021) and Sun and

Abraham (2021), as well as to conventional dynamic OLS estimators. We also verify correct coverage of our inference procedure and check sensitivity of different estimators to anticipation effects.

In our baseline simulation we consider a complete panel of I = 250 units observed in periods t = 1, . . . 6. The event happens for each unit in one of the periods 2-7 with equal probabilities; the cohort E i = 7 is therefore only observed untreated in the sample period. Treatment effects depend on the horizon, as τ it = K it + 1 for it ∈ Ω 1 , but are otherwise homogeneous. We impose Assumptions 1 and 2 and set the FEs to α i = −E i and β t = 3t. Finally, in each of the 500 simulations we generate homoskedastic and mutually independent error terms, ε it iid ∼ N (0, 1). In line with Section 2, we generate the E i realizations only once, viewing them (along with α i and β t ) as non-stochastic. Our target estimands are the ATTs τ h for each horizon h = 0, . . . , 4 observed in the data; while τ 0 is an average of the short-run effects on 205 units, τ 4 corresponds to 41 units only (those treated at E i = 2 and observed at t = 6).

Besides the imputation estimator of Theorem 2, we consider the de Chaisemartin and D'Haultfoeuille OLS standard errors are clustered by unit.

We first compare the imputation estimator to its robust counterparts. Column 1 of Table 2 reports the exact variance of each estimator, for each horizon-specific estimand. In line with Theorem 1, the imputation estimator is most efficient among the robust estimators in all cases, but the simulation is useful in quantifying the magnitude of the efficiency gain. Under homoskedasticity, the while we consider unit FEs, which unlike cohort FEs cannot be estimated consistently in short panels. Column 2 shows that the inference procedures accompanying each of the three estimators perform well. Specifically, we report the simulated coverage: the fraction of the 500 simulations in which a t-test does not reject the null of τ h = h + 1 at the 5% significance level. Coverage is close to 95% in all simulations of Table 2 , and therefore is not reported later.

Since the imputation estimator uses all pre-periods as reference periods, while the alternative estimators only use the period directly preceding treatment, it is not surprising that the efficiency gains are even higher when we add four more pre-periods, t = −3, . . . , 0, in column 3. In this simulation the true variances of the dCDH and SA estimators are 44-97% higher.

In columns 4 and 5 of Table 2 , we report estimator variances under deviations from Assumption 4, such that the relative efficiency of the imputation estimator is no longer guaranteed by Theorem 1. In column 4 we make the error terms heteroskedastic (while still mutually independent): ε it ∼ N (0, σ 2 it ) for σ 2 it = t, such that the variance is higher in later periods. In column 5 we instead suppose that ε it follow a stationary AR(1) process with Var [ε it ] = 1 and Cov [ε it , ε it ] = 0.5 |t−t | , with ε it still Normally distributed and independent across units. The imputation estimator remains the most efficient of the three, with variances of dCDH and SA higher by 2-51% in column 4 and 5-42% in column 5. The only exception is the estimator for h = 0 in column 5, where the alternative estimators are 3-8% more efficient.

Finally, in column 6 we consider the sensitivity of the three estimators to violations of Assumptions 1 and 2. Specifically, we add an anticipation effect of 1/ √ I = 0.0632 to the outcomes of each unit corresponding to the period right before treatment, t = E i − 1, and report the exact bias of each estimator. 43 While the dCDH estimator is always more sensitive to such anticipation effects than SA (except h = 4 where the two estimators coincide), we find no clear relationship between the imputation estimator and its alternatives. The imputation estimator is more sensitive for longer horizons h = 3, 4 more robust for h = 0, 1, and is in between dCDH and SA for h = 2. 44 Table 2 further compares the imputation estimator to OLS, showing that the robustness to treatment effect heterogeneity associated with the imputation estimator comes at a nearly zero efficiency cost for the shorter horizons, h = 0, 1, 2. 45 Across our simulations, the variance of the semi-dynamic OLS estimator is at most 6% lower than that of the imputation estimator. Moreover, the variance of fully-dynamic OLS is in most cases higher than that of the imputation estimator, as the former does not fully impose Assumption 2. OLS estimators similarly do not have a substantially lower sensitivity to anticipation effects. The relative efficiency of the imputation estimator is up to 10% lower than that of semi-dynamic OLS for h = 3 and up to 25% worse for h = 4. At the same time, the extrapolation problems associated with OLS estimation are also strongest for the longest horizons, making robust estimators more valuable.

Taken together, these results suggest that the imputation estimator has sizable efficiency advan- 43 The √ I normalization makes the bias comparable in magnitude to standard errors. 44 There is similarly no clear ranking between the sensitivity of our estimator relative to dCDH and SA when we consider violations of Assumptions 1 and 2 at other horizons Kit = −k, k = 2, . . . , 6 (for the same estimands). This is not surprising since all linear estimators that are robust to arbitrary treatment effect heterogeneity have the same sensitivity to the sum of these anticipation effects, Yit = 6 k=1 1 [Kit = −k] (Proposition A9). While that result only applies when all units are eventually treated, similar results can be obtained in the general case, as long as violations of Assumptions 1 and 2 involve the never-treated group, too. 45 In our simulation treatment effects only depend on Kit, and thus OLS estimators which include all lags of the treatment onset are unbiased. However, adding further treatment effect heterogeneity would introduce bias to the OLS estimators without changing any other conclusions of this section; see Sun and Abraham (2021) and the "fiveestimator" illustration in our Github archive: https://github.com/borusyak/did_imputation. tages over alternative robust estimators, extending even to heteroskedasticity and serial correlation of error terms; in Section 6.3 we confirm these findings in an application with real data. The Monte

Carlo simulations here further highlight that the efficiency gains do not come at a cost of systematically higher sensitivity to parallel trend violations. Moreover, our analytical inference tools perform well in finite samples. Furthermore, the efficiency costs relative to dynamic OLS estimators are low. Naturally, these results may be specific to the data-generating processes we considered, and we recommend that researchers perform similar simulations based on their data.

Our benchmark setting assumed panel data and treatments that happen at different times but stay on forever. We now show that our results extend naturally to a range of related settings used in applied economics, deviating from these benchmark conditions in various ways. We consider three alternative data structures: repeated cross-sections, datasets with two-dimensional cross-sectional variation in one period, and triple-difference designs. We also comment on how our assumptions and results translate to generic datasets which need not have a panel structure. On treatment timing, we discuss conventional DiD designs without staggered timing, scenarios where treatment switches on and off, and settings where the same unit goes through multiple events. We focus on robust and efficient estimation throughout the section but also point out how OLS-based procedures continue to be problematic.

Repeated Cross-Sections. Suppose in each period data are available for different random samples of units i (e.g., individuals) belonging to the same set of groups g(i) (e.g., regions), and treatment timing varies at the group level (e.g. Sansone, 2019) . In that case no estimation with units FEs is possible, as only one observation is available for each unit. However, DiD strategies are still applicable to repeated cross sections, with group FEs replacing unit FEs. In our framework this means replacing Assumption 1 with Y it (0) = α g(i) + β t + ε it . Theorem 1 directly extends to this setting.

Two-Dimensional Cross-Sections. DiD designs are also used when the outcome is measured in a single period but across two cross-sectional dimensions, such as regions i and birth cohorts g (e.g. Hoynes et al. (2016) ; Bennett et al. (2020) ). To fix ideas, suppose some policy is implemented in a set of regions for the cohorts born after some cutoff period E i that varies across regions, such that the treatment indicator is defined as D ig = 1 [g ≥ E i ]. With the untreated potential outcomes modeled in a TWFE way, as Y ig (0) = α i + β g + ε ig , the setting is isomorphic to our benchmark.

Thus, TWFE OLS may suffer from negative weighting, in particular for the oldest groups in the regions with the lower cutoffs. Moreover, the imputation estimator is robust to heterogeneous effects and efficient under homoskedasticity of ε ig . Triple-Differences. In triple-difference designs, the data have three dimensions, such as regions i, demographic groups g, and periods t. Conventional static OLS estimation is based on the regression Y igt = α ig + α it + α gt + τ D igt + ε igt (10) (Angrist and Pischke, 2008, p.181 ) and dynamic versions have been leveraged (e.g. Bau, 2021) .

A prominent class of applications with staggered adoption, following Baier and Bergstrand (2007), is in gravity equations, where Y igt is (log) value of exports from country i to country g in period t, and D igt is an indicator for a free trade agreement between them. For the same reasons as in Section 3.3, the OLS estimand for τ may not properly average heterogeneous effects τ igt when different ig pairs are treated at different times. The imputation estimator based on the model Y igt (0) = α ig + α it + α gt + ε igt is robust and efficient under homoskedasticity.

Generic Data. Ultimately, Theorems 1 and 2 apply to generic datasets with observations indexed by j (which may or may not include a time dimension), if one assumes the analogs of Assumptions 1 , 2 and 3 :

• a model of untreated potential outcomes: Y j (0) = Z j π + ε j for some covariates Z j (perhaps including one or more sets of group FEs) and E [ε j ] = 0;

• that the observed outcome Y j = Y j (0) if the treatment indicator D j is zero;

• and a (possibly trivial) model of treatment effects τ j ≡ Y j − Y j (0) = Γ j θ.

The asymptotic results generalize similarly.

Simultaneous Treatment. Consider conventional DiD designs in which treatment happens at a single date (in the treatment group) or never (in the control group), and the panel is complete.

In this case there are no forbidden DiD comparisons, as those require that a unit switches its treatment status in a period when another unit has already been treated. Thus, only admissible comparisons are available, and OLS estimation does not suffer from negative weights. The presence of a never-treatment group also prevents the underidentification problem.

These nice properties of conventional DiD designs break if more covariates are included (Sant'Anna and Zhao, 2020), in particular in the presence of unit-specific time trends or at least a treatment group-specific trend (as in, e.g., Duggan et al., 2016) . Static OLS specifications estimate unit-specific trends from both pre-and post-treatment data, and therefore contaminate them with the dynamics of treatment effects-an observation first made by Wolfers (2006) . 46 Interestingly, negative weights may also appear in a non-staggered setting without covariates, when the panel is incomplete. In particular, this would happen if, for a certain treated observation it (from the treatment group in a 46 Similarly, the underidentification problem reappears, as the fully-dynamic specification cannot distinguish between a linear path in treatment and anticipation effects and a treatment group-specific trend.

post-treatment period), many pre-treatment outcomes for unit i and many control group outcomes in period t are missing. The mechanics of the issue is similar to the staggered case; see the proof of Proposition 4.

In contrast, the imputation estimator continues to apply, providing robust estimates which are efficient under homoskedasticity.

Treatment Switching On and Off. In some applications, the treatment of interest may switch on and off for the same unit over time. For instance, Martínez et al. (2021) study the effects of a temporary tax holiday introduced across Swiss cantons in a staggered way; see Dean (2021) for another example. Our results extend directly if it is appropriate to write Y it = α i + β t + τ it D it + ε it and therefore extrapolate the TWFE outcome structure from the untreated to the treated periods, regardless of how they are ordered relative to each other.

This characterization of Y it , however, here requires an additional assumption that there are no within-unit spillovers from the periods of treatment to the future untreated periods. If the lags of the treatment onset affect current outcomes in periods with D it = 0, the observed outcomes may not equal the never-treated potential outcome Y it (0) even if there are no anticipation effects. All periods since the first treatment date may thus be contaminated by treatment. The imputation approach is therefore applicable when treatment effects are heterogeneous across units and periods but not dynamic, i.e. the potential outcome today depends only on the treatment status today. 47

Non-Binary Treatments. Our framework also applies to treatments that switch from zero to multiple (discrete or continuous) values, which may or may not change over time once nonzero. For instance, Broda and Parker (2014) analyze the marginal propensity to spend (MPX) out of the 2008 economic stimulus payments (ESP), which was disbursed in a staggered way. While some specifications use the indicator of any ESP as a binary treatment, others leverage the dollar amount of the ESP receipt, ESP it . The imputation estimator applies with no change: the FEs can be estimated using untreated observations only, yielding unbiased estimates of treatment effects, Y it −Ŷ it (0). The richer structure of treatment allows for a broader class of estimands: one could, for instance, compute the average per-dollar MPX, by averaging Y it −Ŷ it (0) /ESP it across treated observations, or the total effect of the stimulus package by averaging Y it −Ŷ it (0) without normalizing them.

Multiple Events per Unit. Our framework applies to settings where units experience more than one event of interest. Causal identification then requires restrictions on treatment effect heterogeneity which may be introduced via Assumption 3.

Consider, for instance, Adda (2016) who studies the effects of school holidays on epidemics.

He leverages school holidays that happen in a staggered manner across regions, but his data span 47 Another assumption that becomes less natural when the treatment may switch on and off is the asymmetry between several years and therefore multiple holidays. If each holiday is viewed as a separate event with its own effects which may potentially last forever and change over time, causal identification of holidayspecific effects is impossible: one cannot distinguish between the effects of different past holidays. However, with the events sufficiently spaced out in time, natural restrictions may be introduced to restore identification. For instance, one may be willing to assume that holidays can have no effects more than a few weeks after, which is still well before the next holiday, or that they stabilize for each unit after that period of time, even if not at zero. Alternatively, one may assume that the path of treatment effects is the same across different holidays for the same regions. Such assumptions imply different "true" models of outcomes Y it which have a lot of flexibility, yet enough structure for identification. Analogs of Theorem 1 apply.

In this section, we revisit the estimation of the marginal propensity to spend in the event study of Broda and Parker (2014) .

The marginal propensity to spend out of tax rebates is a crucial parameter for economic policy. In the US, the Economic Stimulus Act of 2008 consisted primarily of a 100 billion dollar program that sent tax rebates to approximately 130 million tax filers; the tax rebate component of the Coronavirus Aid, Relief, and Economic Security (CARES) Act of 2020 amounted to around 300 billion dollars.

Whether such policies were effective at boosting the economy and counteracting economic crises depends crucially on the extent to which they directly raised household spending.

A recent literature, in particular Parker et al. (2013) and Broda and Parker (2014) , estimates the marginal propensity to spend (MPX) out of the 2008 tax rebates. 48 The tax cuts varied across households in amount, method of disbursement, and timing. Typically, single individuals received between $300 and $600, while couples received between $600 and $1,200; households additionally received $300 per child who qualified for the child tax credit. The rebate was disbursed in one of two methods: via direct deposit to a bank account, if known by the IRS, or a paper check mailed to the home address otherwise. Within each method, the timing of disbursement was determined by the final two digits of the recipient's Social Security Number, according to a schedule announced in advance. Broda and Parker (2014, henceforth BP) use an event study design to examine the response of nondurable spending to tax rebate receipt. They leverage the quasi-experimental variation in the timing of the receipt, limiting their sample to households who report receiving the payment within 48 Earlier work by Johnson et al. (2006) analyzes similar payments under The Economic Growth and Tax Relief Reconciliation Act of 2001, while a recent paper by Parker et al. (2022) evaluates the Economic Impact Payments of 2020. The literature provides other estimates of the marginal propensity to spend using variation from lottery winners (e.g., Fagereng et al. (2021) ) or earnings shocks (e.g., Baker (2018) and Kueng (2018) ). The MPX estimates from the Economic Stimulus Act of 2008 are widely used to calibrate macroeconomic models because they offer direct evidence on the impact of tax policy on consumption behavior. the planned period. The rationale for this choice is that the last two digits of the Social Security Number, which determined the timing, are as-good-as-randomly assigned, justifying parallel trends in expenditures. 49 The no anticipation assumption may also be expected to hold: although the disbursement schedule was known in advance, households were directly notified by mail only several days before disbursement. Event studies are especially useful for estimating MPXs because of the focus on the dynamics of the impulse response, which is crucial for both policy analysis and calibrating macroeconomic models. We note that, although the MPX is a very informative moment to discipline macroeconomic models of stabilization policy, it can only be used to estimate the change in household spending directly caused by the receipt of the tax rebates and inherently ignores general equilibrium effects, e.g. due to Keynesian multipliers and price changes.

We estimate the performance of various estimators at estimating the impulse response function of nondurable spending to tax rebate receipt using the same data as BP. While earlier work by Parker et al. (2013) estimates the impulse responses using quarterly spending data from the Consumer Expenditure Survey, BP leverage more detailed data from the Nielsen Homescan Consumer Panel (NCP).

The Nielsen dataset tracks transactions at a much higher (in principle, daily) frequency, which is why we choose it as our main dataset. The Nielsen data cover expenditures on consumer packaged goods (food, beverages, beauty and health products, household supplies, and general merchandise), representing around 15% of total household expenditures. Our dataset, identical to that of BP, is a complete panel of 21,760 households (including 21,690 with non-missing disbursement method information) observed over 52 weeks of year 2008. Appendix Figure A1 shows the distribution of receipt weeks, by disbursement method.

We replicate BP's estimates of the MPX and show how they suffer from an upward bias due to the choice of a binned OLS specification. For now we follow BP in focusing on the first three months since the receipt; we leave the longer-run effects to Section 6.2.2.

BP estimate dynamic OLS specifications of the form:

where Y it is the dollar amount of spending in calendar week t for household i, α i are household FEs, and β t are week FEs. In some specifications, week FEs are interacted with the disbursement method m(i) (i.e., β m(i)t is included instead of β t in (11)) to leverage the variation in timing within 49 Thakral and Tô (2020) point out that for the paper check group pre-rebate household characteristics (in levels), such as average weekly spending, are not balanced with respect to the timing of the receipt, possibly because of misreporting of the receipt day. While this is problematic for randomization-based approaches to DiD (e.g. Arkhangelsky and Imbens (2019) and Roth and Sant'Anna (2022) ), parallel trends in expenditures may still hold. Indeed, we fail to reject them with pre-trend tests below. each disbursement method and not across; we refer to those specifications as "with disbursement method FEs." The set of 1 [K it = h] are the lead/lag indicator variables tracking the number of weeks K it = t − E i since the week of the tax rebate receipt for the household, E i ; b is chosen such that all possible lags in the sample are covered (and a varies, as discussed below). MPXs for each horizon, as well as pre-trend coefficients, are captured by τ h . Regressions are weighted by the Nielsen projection weights.

BP's preferred specification is a binned version of (11) which constrains τ h to be constant across four-week periods -"months" -around the event, starting with the week of tax rebate receipt: e.g., τ 0 = · · · = τ 3 . This specification also includes one monthly pre-trend coefficient, i.e. a = 4 with τ −1 = · · · = τ −4 . These estimates are replicated in Table 3 , column 1: Panel A reports the results without disbursement methods FEs, while Panel B includes these FEs. 50 According to these estimates, tax rebate receipt led to an increase in spending in the contemporaneous month of $42.6 (s.e. 7.2) in Panel A to $47.6 (s.e. 9.2) in Panel B, and a cumulative increase over three months of $60.5 (s.e. 25.7) in Panel A to $94.4 (s.e. 33.5) in Panel B. Expressed as a fraction of the average tax rebate amount, these estimates correspond to a three-month cumulative MPX of 6.7% in Panel A and 10.5% in Panel B. 51 BP then scale these MPX estimates to extrapolate from the sample of consumer packaged goods to the overall expenditure patterns. As discussed in greater detail in Section 6.2.3, their calculations using the preferred specification (i.e., without disbursement method FEs, as in our Panel A) imply that the propensity to spend from a tax rebate is between 51 and 75 percent over a quarter. These very large MPX estimates (and similar estimates by Parker et al.

(2013)) have been influential to calibrate the latest generation of macroeconomic models of fiscal stabilization.

Next, we show that the choice of binned OLS leads to a substantial upward bias in estimated MPXs. In column 2 of Table 3 we report the estimates from specification (11) without binning and with one weekly lead (a = 1), as in BP's Table 3 . We report the coefficients aggregated to the monthly level. The MPX for the contemporaneous month falls from $42.6 (s.e. 7.2) to $35.0 (s.e. 5.8) in Panel A and from $47.6 (s.e. 9.2) to $27.9 (s.e. 7.8) in Panel B. The fall in MPX is much larger for the cumulative three-month changes, from $60.5 (s.e. 25.7) to $26.8 (s.e. 21.4) in Panel A and from $94.4 (s.e. 33.5) to $9.6 (s.e. 34.4) in Panel B. In column 3, we use the robust and efficient imputation estimator to estimate weekly average responses and aggregate them to the monthly level.

The point estimates are similar to column 2 for the contemporaneous month response, while for the quarterly MPX they are in between the results obtained with monthly binned OLS and dynamic OLS.

The difference between the binned OLS and other specifications could originate from three distinct sources. First, if the DiD assumptions are violated, different estimators can produce different 50 The results are identical to BP's Table 4 , columns 1 and 4, respectively. 51 These estimates in percent are obtained by dividing the dollar estimates by the average rebate amount of $897.86. They differ slightly from the estimates reported by BP (Table 4 , columns 3 and 6, where the corresponding estimates are 6.9% for our Panel A and 12.3% for our Panel B) who reestimate the regressions rescaling the treatment leads and lags by the average rebate amount, overall or by disbursement type. Their method changes both the sample (dropping households with a missing rebate amount) and, with disbursement FEs, the estimand. Notes: In Panel A, column 1 estimates the binned version of OLS specification (11) with a = 4 and imposing that the coefficients are the same in each month, i.e. four weeks since the rebate receipt. Column 2 estimates the same specification without binning, with a = 1, and aggregates the coefficients within each month. These specifications are identical to Broda and Parker (2014) , Tables 3 and 4, column 1. Column 3 reports the efficient imputation estimator. All columns aggregate coefficients by month for the first three months after the rebate receipt and suppress the other coefficients. Panel B additionally interacts week fixed effects with the disbursement method dummies. Columns 1 and 2 are identical to Broda and Parker (2014) , Tables 3  and 4 , column 4. The estimates in column 3, Panel B exclude the last week of the quarter (h = 11) due to insufficient sample size. All estimates use projection weights from the Nielsen Consumer Panel, and standard errors are clustered by household. Notes: Panel A reports estimates of the response of spending to tax rebate receipts and pre-trend coefficients, using OLS specification (11) with a = 8 and without binning ("OLS") and and the efficient imputation estimator and the pre-trend test from Section 4.4 ("Imputation" Table 3 , column 1, produce sizable (and sometimes significant) MPX estimates one and even two months after the receipt, and larger contemporaneous month effects?

Using the theoretical insights developed in this paper, we find that this discrepancy is explained by the short-run bias of the estimand implicitly chosen by the binned OLS specification. Figure 3 shows the weights with which the quarterly MPX estimated from the binned OLS specification of Notes: This figure reports the cumulative weight that the binned OLS estimator of the quarterly MPX from Table 3 , column 1, with or without disbursement methods fixed effects, places on the true effects at each horizon h = 0, . . . , 11 weeks since the rebate receipt. These weights are computed using the Frisch-Waugh-Lovell theorem, as in Equation (18) (including other monthly coefficients on the right-hand side of the auxiliary regression that producesD it ), and aggregated across the first three months since the rebate receipt. The black dashed line indicates the weight corresponding to the true quarterly MPX, i.e. a simple sum of the effects at each horizon.

estimand of binned OLS diverges from the true quarterly MPX, which is a simple sum of the effects at each horizon h = 0, . . . , 11 weeks, i.e. with constant weights of one on each week. 53

The binned OLS specification puts a large weight on the first week, which generates a large upward bias given that the spending response is concentrated in the first weeks, as shown in Figure 2 .

In the specification without disbursement method FEs, the weight placed on the first-week response is three times larger than it would be with an equally weighted sum; it is five times larger with the FEs. Furthermore, within each month the weights become negative for the last weeks of the month.

To assess to what extent the short-run biased weighting scheme due to binning explains the difference between columns 1 and 2 of Table 3 , Panel A, we apply the weights of binned OLS across weeks (underlying the specification in column 1) to the OLS estimates without binning (underlying column 2). We obtain a point estimate of $42.6 for the contemporaneous month (almost identical to column 1, instead of $35.0 in column 2) and $60.4 for the quarter (compared with $60.5 in column 1, instead of $26.8 in column 2). Thus, the short-run biased weighting scheme due to binning explains hand side of the auxiliary regression that producesDit). Then they are aggregated across households and across the three monthly coefficients. 53 The binned OLS estimand also diverges from the true MPX in how it weights different households for the same weekly horizon. We focus on the variation across horizons here because MPXs have a very strong dynamic pattern (Figure 2 ) which, as we show, turns out to explain most of the gap between the estimates with and without binning. nearly all the difference between columns 1 and 2 of Table 3 , Panel A. 54, 55

In this section, we examine the long-run dynamics of MPXs obtained with OLS estimators and the imputation estimator. The timing of the tax rebate is such that we simultaneously observe treated and untreated households for at most 13 weeks. 56 Per Proposition 5, it is not possible to estimate causal effects beyond 12 weeks since the receipt via DiD methods without restrictive assumptions on treatment effect heterogeneity. In what follows, we highlight that dynamic OLS specifications still produce estimates for longer horizons via extrapolation, and we examine whether, in our application, the estimates obtained in this way could paint a misleading picture of the long-run dynamics of MPXs.

In Figure 4 , we use the same specifications as in Table 3 but we report the full set of dynamic estimates for the treatment effects. Panel A reports the estimates from the binned OLS specification.

With disbursement method fixed effects, the point estimates are large and positive for all nine months following the receipt of the tax rebate. Thus, due to the extrapolation implicit in the OLS estimator, this specification could be mistakenly interpreted as evidence for a very large and persistent increase in spending. Without these fixed effects, the estimates tend to hover around zero.

In Panel B, we show OLS estimates without binning, as in Table 3 , column 2. Here both specifications with and without disbursement method fixed effects yield point estimates that are almost all negative in the long run. Taken at face value, these estimates could misleadingly suggest that households intertemporally substitute consumption by making purchases at the time of tax rebate that they would have made 20 to 30 weeks later. As in Panel A, these point estimates are noisy but could lend themselves to some economic interpretation.

In contrast, Panel C describes the results from the robust imputation estimator, which does not allow extrapolation in the absence of an explicit control group. This panel shows that, for the horizons for which imputation is possible, there is no evidence of any impact on spending beyond two to four weeks after tax rebate receipt. The patterns are the same both with and without disbursement fixed effects. These results highlight the practical relevance of the insights from Section 3.4: the imputation estimators avoid extrapolation, thus eliminating seemingly unstable patterns found across OLS specifications.

Finally, in Figure 5 we illustrate the importance of the insights on the underidentification of fully-dynamic OLS specifications from Section 3.2. Unlike earlier specifications, which only included 54 Short-run biased weighting also explains the majority, although not all, of the difference between columns 1 and 2 of Table 3 , Panel B, especially for the more precisely estimated contemporaneous month. Specifically, applying the binned OLS weights to the OLS specifications without binning, we get an estimate of $40.0 for the contemporaneous month and $69.0 for the quarter, thus reducing the discrepancy between columns 1 and 2 by 62% and 70%, respectively. 55 BP motivate binning by statistical precision: "by estimating fewer parameters, longer-term spending effects of the receipt may be estimated more precisely" (p. 29). A comparison of standard errors in columns 1 and 2 of Table 3 does not find support for that rationale, and thus for any trade-off between a more desirable estimand and estimation efficiency.

56 Appendix Figure A1 shows that the first treated households received the rebate during week 17 of 2008 (week ending April 26), while the last treated households received it during week 30 (week ending July 26). a small number of treatment leads, here we run the OLS specification (11) with a full set of weekly leads and lags around tax rebate receipt. We drop two leads since the set of dynamics lead and lag coefficients is only identified up to a linear trend, as discussed in Section 3.2. We find that the fully-dynamic OLS estimates change drastically depending on which two leads are dropped. We illustrate this by comparing the MPCs when dropping leads h = −1 and −2, or h = −3 and −4.

With or without disbursement method fixed effects, the dynamic path is very sensitive to the choice of leads to drop. This illustrates another source of instability in conventional practice, which the imputation estimator directly avoids. Notes: This figure reports MPX and pre-trend estimates and 95% confidence bands for specification (11) with all leads and lags of the tax receipt included, except for two chosen as indicated. Panel A proceeds without disbursement methods fixed effects interacted with week fixed effects, while Panel B includes them. Standard errors are clustered by household.

We now discuss the implications of our findings for the macroeconomics literature. We proceed in two steps: selecting our preferred MPX estimate for the Nielsen products based on Section 6.2.1 and then extrapolating it to broader consumption baskets, following the strategy of BP.

Our preferred estimate for the average cumulative MPX out of the tax rebate for the Nielsen products is $30.5, corresponding to the imputation estimator with disbursement method FEs (Table 3, Panel B, column 3) in the first month since the rebate. This constitutes 3.4% of the average rebate amount. We choose the specification with disbursement method FEs because the variation in timing is more plausibly exogenous within disbursement methods and across (both ex ante, due to the institutional setting, and ex post, as shown by Thakral and Tô (2020)). We focus on the first (i.e., contemporaneous) month and impose zero effects for the following months based on the evidence from Figures 2 and 4 that the MPXs rapidly decay to zero, while estimation noise increases. 57

Finally, we choose the imputation estimator over OLS for its robustness properties. In contrast to column 1 of Table 3 , it avoids the short-term bias due to binning. Moreover, in contrast to column 2 it ensures equal weighting across all post-rebate observations for which imputation is possible, although the estimates are similar for the contemporaneous month. 58 Conveniently, robustness to treatment effect heterogeneity is gained without an efficiency loss in this application: the standard errors are similar across columns of Table 3 for the effects in the contemporaneous month (and even 57 Our preferred estimate is robust to the choice of the time window: the cumulative MPX would have been similar (at $25.7 instead of $30.5) if we focused on the first two weeks only. 58 The set of households for whom the MPXs are estimable without restricting heterogeneity is smaller for longer horizons. In an unreported robustness check, we have verified that the MPX estimates are very similar (at $28.5 instead of $30.5) if restricting the set of households to be balanced across horizons h = 0, . . . , 3 weeks. one month after).

To obtain MPX estimates covering the full consumption basket, BP propose to rescale the estimates obtained with the Nielsen data. In BP, this scaling is done in three different ways: (i) by the ratio of spending per capita in the National Income and Product Account (NIPA) and

Nielsen data; (ii) by the ratio of the self-reported change in spending on all goods after the rebate relative to that on Nielsen goods alone; (iii) by a factor based on the relative shares of spending and relative responsiveness to the rebate across subcategories of goods as measured in Consumer Expenditure Survey (CE). Using these three approaches and BP's preferred MPX estimate (based on the specification of our Table 3 , Panel A, column 1), they estimate that the tax rebate raised the Figure 6 reports these patterns. Thus, our estimate implies a 40% smaller response of consumption expenditures in 2008Q2, and 75% smaller in 2008Q3. This difference stems from the divergence between our preferred estimates at the individual level: while BP conclude that the propensity to spend at the individual level from a tax rebate over three months since the rebate is between 51 and 75 percent, our preferred estimates are half of that: between 25 and 37 percent. 59

59 We obtain these estimates by replicating the first row of Panel A of BP's Table 5 and using our preferred event Notes: This table reports the first-quarter MPX and MPC using the preferred binned OLS specification of Broda and Parker (2014) and our preferred specification based on the imputation estimator. The first row reports the marginal propensity to spend on products included in the Nielsen sample. The second row rescales these estimates to extrapolate them to the marginal propensity to spend on all goods using the three rescaling methods from Broda and Parker (2014) . The ranges correspond to the lowest and highest values among the three rescaling methods. To obtain the estimate for the nondurables MPX in the third row, we use the scaling factor of Laibson et al. (2022) , who show that the total MPX is equal to 3.6 times the nondurables MPX. The fourth row also follows the methodology of Laibson et al. (2022) and reports the model-consistent ("notional") MPC that can be used as a target for macroeconomic models, equal to the total MPX divided by 3.2.

In Table 4 , we summarize the MPX estimates for the first quarter after tax rebate obtained with BP's and our preferred specification. The first row reports the observed marginal propensity to spend on products included in the Nielsen sample during that quarter. The next rows rescale these estimates to extrapolate the marginal propensity to spend to broader samples, i.e. the full consumption basket (second row) and nondurables (third row). For the full consumption basket, we implement the three scaling procedures from BP and report the lower and upper bounds; for nondurables we leverage the scaling method of Laibson et al. (2022) . The fourth row reports the model-consistent, or "notional," marginal propensity to consume (MPC) that can be used as a target for macroeconomic models, also following the methodology of Laibson et al. (2022) . 60 The estimates based on BP in column 1 are closely in line with the literature: typical estimates of the quarterly MPX for all expenditures range from 50-90%, while estimates of the quarterly MPX for nondurable expenditure range from 15-25%. 61 In contrast, the imputation estimator in column 2 of Table 4 delivers estimates that are about half as large in all rows. These smaller MPC estimates imply a lower effectiveness of fiscal stimulus.

Thus, our new estimates for the impact of the 2008 fiscal stimulus on the U.S. economy yield two lessons for the calibration of macroeconomic models: (1) that the targeted MPC should be significantly smaller -about half as large -and (2) that it is best to calibrate the model using study estimates. 60 Standard macroeconomic models assume a notional consumption flow that does not distinguish between nondurables and durable consumption. Prior to Laibson et al. (2022) showing that the notional MPC should be the relevant target, state-of-the-art macroeconomic models targeted nondurable MPX estimates. For instance, Kaplan and Violante (2014) targeted the estimates from Johnson et al. (2006) , which are quantitatively similar to those from BP when rescaled as in Table 4 , despite using more aggregated data and a different rebate episode. weekly-level estimates of the MPC, as we report in Figure 2 , rather than monthly or, especially, quarterly MPC estimates, which are much noisier. Indeed, models should reflect that most of the spending response occurs in the very short run, in the first two to four weeks after tax rebate receipt.

This strong lack of consumption smoothing may be inconsistent with some of the economic channels in state-of-the-art macroeconomic models. 62

Finally, we compare the efficiency of the imputation estimator to the alternative robust estimators of de Chaisemartin and D'Haultfoeuille (2021) and Sun and Abraham (2021) and (abbreviated dCDH and SA, as before). These results validate the findings from the Monte Carlo simulations of Section 4.6 using real-world data.

We document the in-sample efficiency gains in Figure 7 by showing the point estimates and confidence intervals for weekly average MPXs based on the imputation estimator and the two alternatives in Panel A. We use the specification without disbursement fixed effects. 63 The point estimates are very similar for dCDH and the imputation estimator, but they differ from those of SA, because this estimator uses a much smaller control group (only the households who received the rebate in the latest possible week) and is therefore much noisier. Panel B zooms in on the efficiency comparison by reporting the lengths of the confidence intervals for SA and dCDH relative to that of the imputation estimator.

The differences are large: the confidence interval from dCDH is about 50% longer for all periods, and 2-3.5 times longer for SA. In Appendix A.12 we confirm these efficiency gains, obtained from a single sample, using a Monte Carlo study based on a data-generating process that closely resembles the actual data.

In this paper we revisited a popular class of empirical designs: event studies, or difference-indifferences with staggered rollout. We provided a unified framework that formalizes an explicit set of goals and assumptions underlying event study designs, reveals and explains challenges with conventional practice, and yields an efficient estimator. Focusing on robustness to treatment effect heterogeneity, we first showed that conventional OLS methods suffer from identification and negative weighting issues that we related to the conflation of estimation targets, fundamental assumptions 62 For completeness, in Appendix Figure A2 , we report imputation-based MPX estimates by household group, defined by income or liquidity, paralleling BP's Tables 7 and 8. These moments can also help discipline macroeconomic models. We find that illiquid households have a significantly higher MPX, consistent with the results of BP. While BP suggest that the MPX (when measured in percent of the average rebate amount) may be non-monotonic in income, our estimates suggest that the MPX is declining with income, although the difference is less pronounced across income groups than across liquidity groups and more noisy. The key result that MPXs quickly decay to zero over time is preserved.

63 Unlike Section 4.6, here we implement the dCDH method using the csdid Stata command developed for the Callaway and Sant'Anna (2021) estimator: the two estimators are identical absent additional controls (see Section 4.5), and csdid allows for projection weights. on untreated potential outcomes and anticipation effects, and auxiliary assumptions on treatment effect homogeneity.

We then solved for the efficient estimator within our framework. In a baseline case where treatment-effect heterogeneity remains unrestricted, this robust and efficient estimator takes a particularly simple "imputation" form that estimates fixed effects among the untreated observations only, imputes untreated outcomes for treated observations, and then forms treatment-effect estimates as weighted averages over the differences between actual and imputed outcomes. We then developed results for asymptotic inference and testing and compared our approach to other estimators. Our characterization of efficient unbiased estimators naturally extends to a number of related settings. In particular, it applies to any linear model of untreated potential outcomes and unrestricted treatment-effect heterogeneity, including models that do not explicitly include fixed effects.

We also highlighted the importance of separating testing of identification assumptions from estimation based on them; such separation both increases estimation efficiency and helps address inference biases due to pre-testing.

Finally, we illustrated the practical relevance of our theoretical insights by revisiting the estimation of the MPX out of tax rebates in the event study of Broda and Parker (2014) . Our preferred estimates are about half of the benchmark quarterly MPX estimates used to calibrate state-of-the-art macroeconomic models and are more short-lived, implying that fiscal stimulus may be significantly less effective than predicted by existing calibrations.

Sant'Anna, Pedro H.C. and Jun Zhao, "Doubly robust difference-in-differences estimators,"

Journal of Econometrics, 2020, 219 (1), 101-122.

Schmidheiny, Kurt and Sebastian Siegloch, "On Event Study Designs and Distributed-Lag Models: Equivalence , Generalization and Practical Implications," Working Paper, 2020.

Stock, James H. and Mark W. Watson, "Heteroskedasticity-robust standard errors for fixed effects panel data regression," Econometrica, 2008, 76 (1), 155-174.

Strezhnev, Anton, "Semiparametric weighting estimators for multi-period difference-in-differences designs," Working Paper, 2018.

Sun, Liyang and Sarah Abraham, "Estimating Dynamic Treatment Effects in Event Studies with Heterogeneous Treatment Effects," Journal of Econometrics, 2021.

Thakral, Neil and Linh T. Tô, "Anticipation and Consumption," Working Paper, 2020.

Results," American Economic Review, 2006, pp. 1802-1820.

Wooldridge, Jeffrey M, "Two-Way Fixed Effects, the Two-Way Mundlak Regression, and Event Study Estimators," Working Paper, 2021.

Xu, Yiqing, "Generalized synthetic control method: Causal inference with interactive fixed effects models," Political Analysis, 2017, 25 (1), 57-76.

In this section, we consider the consequences of trimming around event time in a numerical example.

We consider five equal-sized cohorts treated in periods E i = 5, . . . , 9 and observed in periods t = 1, . . . , 12, with Assumptions 1 and 2 satisfied in the complete panel. We suppose the researcher decides to trim the sample, keeping four untreated (K it = −4, . . . , −1) and four treated (K it = 0, . . . , 3) periods for each unit. We show that the short-term bias and negative weighting of static TWFE OLS persist with trimming. Using the Frisch-Waugh-Lowell theorem, we compute that cumulative weights that static TWFE OLS puts on horizons 0, . . . , 3 are 0.875, 0.425, 0.025, and -0.325, respectively (with the penultimate weight combining positive and negative weights on different cohorts). There is more negative weighting with trimming than in the complete panel: the total of all negative weights is −0.367 with trimming, compared to −0.316 without.

The challenges pertaining to dynamic specifications persist, too. We consider the semi-dynamic specification which includes all lags and no leads of the event, with or without trimming. 64 In our example, we find that the OLS estimands τ 0 , . . . , τ 3 are less homogeneous in trimmed samples in terms of the composition of cohorts underlying them. Figure A3 reports the weights that τ h places on the observations h periods after treatment across various cohorts, for h = 0, . . . , 3. Panel A, which corresponds to the trimmed sample, shows that all estimands place higher weights on earlier-treated cohorts, but much more so for larger h. This is in contrast to the complete panel (Panel B), where the differences both across cohorts and across h are much smaller.

Spurious identification of long-run effects can also be reinforced by trimming, as the observations for late-treated units in early periods are dropped. In our example, there are no admissible DiD comparisons for any unit observed three periods after treatment in the trimmed sample, making τ 3 identified through extrapolation of treatment effects only. In contrast, admissible comparisons are available in the complete panel: the cohort treated at E i = 5 and observed at t = 8 can be compared to the cohort treated at E i = 9 and to any period t = 1, . . . , 4 when both cohorts are not yet treated. 65

In this section, we provide representations of unbiased estimators, both efficient and not, including for the case when a non-trivial treatment-effect model is imposed. For brevity of notation, we write

where all parameters λ i and δ are collected into a single column vector π, with the corresponding covariates collected in Z it . We further let Z be the matrix with N rows Z it , and Z 1 and Z 0 its restrictions to observations Ω 1 and Ω 0 , respectively. Under Assumptions 1 and 2, we can therefore write Y it = Z it π + D it τ it + ε it .

We first show that even when a non-trivial model τ = Γθ is imposed, the imputation result for unbiased estimators from Proposition 6 applies with respect to an adjusted estimand.

Proposition A1 (Imputation representation of unbiased estimators with a non-trivial treatment effect model). Under Assumptions 1 and 2, any linear estimatorτ w of τ w that is unbiased when the model τ = Γθ is imposed can be written as a linear estimator of some alternatively weighted estimand

that is unbiased without restrictions on the treatment effects. In particular, the imputation representation in Proposition 6 still applies withτ w = it∈Ω 1 v itτit in the third step. The

We now provide explicit expressions for the weights implied by the the efficient estimatorτ * w , both with and without Assumption 3.

Proposition A2 (Weight representation of efficient estimator). The efficient estimator from Theorem 1 can be represented asτ

and that does not depend on the realization of the Y it . In the special case of

With a non-trivial Assumption 3 , we can characterize these weights by a combination of variance minimization for the treated observations and imputation for the untreated observations.

Proposition A3 (Characterization of weights in terms of imputation and variance minimization).

With a non-trivial model τ = Γθ for the treatment effects, the efficient estimator from Theorem 1 can be written as the efficient imputation estimator from Theorem 2 under unrestricted heterogeneity with alternative weights v * 1 on the treatment effects, which solve the variance-minimization problem

where Φ = I − Z 1 (Z Z) −1 Z 1 is the variance of the OLS estimator of τ in the case of homoskedastic errors with unit variance and unrestricted treatment-effect heterogeneity.

The characterization of efficient weights in terms of the minimization problem clarifies that weights v * 1 can differ from weights w 1 if treatment-effect estimatesτ it can be combined in a way that reduces variance according to the variance-covariance matrix Φ −1 of the unrestricted OLS estimator of τ (under homoskedasticity and normalizing the variance of errors to one), while ensuring that the expectation of the resulting estimator is still τ w .

In this section, we spell out the high-level conditions on weights used in Section 4.2. In order to extend consistency to asymptotic Normality, we impose an additional assumption on the concentration of weights:

Assumption A1 (Higher moments of weights). There exists κ > 0 such that E |ε it | 2+κ is uniformly bounded and

In order to establish valid inference, we require additional conditions. First, we assume thatδ is close to δ in the sense of a mean-squared error of weighted fitted values:

Assumption A2 (Consistent estimation ofδ). For the OLS estimatorδ * of δ we assume that

This condition expresses that the fitted values X itδ * are close to X it δ according to a norm given by the weights on related units. We develop sufficient conditions below for the case of short panels when δ expresses period fixed effects.

Second, we impose additional moment bounds: 

In this section we develop low-level sufficient conditions on the weights w 1 on treated observations and on cohort sizes in the case of a panel with I units and T time periods with respective fixed effects and no other covariates. We first state sufficient conditions for consistency in a panel where the number of periods T is allowed to grow slowly. Below, we add more restrictive conditions to also achieve asymptotic Normality and valid conservative inference.

Assumption A4 (Low-level sufficient conditions for consistency). Assume that in the first period every unit is observed and not treated, and that 1.

→ 0, that is, the weights on treatment effects fulfill a (clustered)

Herfindahl condition;

→ 0, that is, the Herfindahl concentration of unit net weights decreases fast enough;

→ 0, that is, the sum of squared total weight on observations treated at t relative to the number of untreated observations in the same period vanishes sufficiently quickly.

The first two conditions express that the weights do not concentrate on too few units. They are similar, but not redundant unless T is fixed; when some weights within a unit are negative and some positive, the weights may cancel out within units, yielding the second condition even when the first one is not fulfilled. The three conditions address different sources of variation of the efficient estimatorτ * w : the first condition bounds the variation from the treated observations themselves; the second, from estimating unit FEs from the untreated observations; and the third, from estimating period FEs from the untreated observations. Together with the conditions in the main text, Assumption A4 yields consistency.

Proposition A4 (Consistency under low-level sufficient conditions). Consider the estimatorτ * w for a panel with two-way fixed effects (Assumption 1), no anticipation effects (Assumption 2), treatment effects that vary arbitrarily (trivial Assumption 3), and clustered error terms (Assumption 5).

Suppose Assumption A4 holds. Thenτ * w from Theorem 1 is consistent for τ w .

Next, we develop sufficient conditions that will imply asymptotic Normality and valid inference in the special case of a complete panel with a fixed T .

Assumption A5 (Low-level sufficient conditions for asymptotic Normality and inference). The panel is complete, T is fixed, |τ it |, |τ it | and E ε 4 it are uniformly bounded, and 1. There is some uniform constant C such that for all t and i, j with E i = E j , D it = 1 = D jt and w it = 0, we have that w jt = 0 and |w it | |w jt | ≤ C, that is, weights within cohort and period do not vary too much;

i;E i =e 1 → ∞ for e = 2, . . . , T, ∞, that is, the size of all cohorts grows. 66

If we add the latter conditions, we also achieve asymptotic Normality.

Proposition A5 (Asymptotic Normality in short panels). Consider the estimatorτ * w for a panel with two-way fixed effects (Assumption 1), no anticipation effects (Assumption 2), treatment effects that vary arbitrarily (trivial Assumption 3), and clustered error terms (Assumption 5). Suppose Assumptions A4 and A5 both hold and the variance ofτ * w does not vanish too quickly, lim inf n H σ 2 w > 0. Thenτ * w from Theorem 1 fulfills the conditions of Proposition 8, and is therefore asymptotically Normal in the sense that σ −1 w (τ w − τ w ) d → N (0, 1).

Finally, we show that these conditions are also sufficient for obtaining consistent variance estimates.

Proposition A6 (Consistent variance estimation in short panels). Consider the estimatorσ 2 w from Theorem 3, and suppose Assumptions 1, 2, 3 , 5, A4 and A5 hold. Thenτ * w from Theorem 1 fulfills the conditions of Theorem 3 whenτ it are equal to an overall average or to cohort-period averages calculated as in (8).

We note that the conditions Assumption A4 and Assumption A5 from this section are fulfilled in particular in the common case of fixed T , growing cohort sizes, and weights that are bounded in the sense that it∈Ω 1 |w it | < C and are constant within cohort-period cells, w it = w jt for t ≥ E i = E j .

The variance estimator in Theorem 3 is asymptotically conservative, since it includes the variation

≥ 0 of the treatment effects around their averagesτ it . Here, we consider reasonable choices for these averages. As discussed in Section 4.3, a natural conservative choice is to estimate a single averageτ , and setτ it =τ . The choice ofτ that minimizes σ 2

Indeed, σ 2 τ (τ ) is convex inτ , and the first-order condition

locates the above solution. A natural estimator is its sample analog. 67

When multiple group-wise averages are estimated, (8) should be viewed as a heuristic extension of (13). The optimal solution forτ g is generally more complex, as it may depend on treatment effect estimates and weights outside the group. For concreteness, consider the case where averagesτ et vary by cohort E i = e and period t, yielding excess variance σ 2

. Then the first-order conditions

have to be solved for each cohort simultaneously across t, provided that the estimator puts non-zero weight on multiple periods within the same cohort. The exception is when only one period for every cohort receives non-zero weight, as when estimating the ATT for a given number of periods since treatment. In that situation the optimal solution

coincides with Equation (13).

Here we formalize the leave-out conservative variance estimator for τ w , contrast it to leave-out variance estimators from prior work, and provide a computationally efficient way of obtaining them.

As in Equation (8), suppose Ω 1 is partitioned into groups of treated observations given by G g .

Let v ig = t;it∈Gg v it andT ig = t;it∈Gg v itτ * it /v ig (with an arbitrary value if v ig = 0). Then our 67 Also note that the denominator of (13) is zero if and only if the estimand makes only within-unit comparisons of treatment effects over time; in that case the choice ofτ is inconsequential, as it cancels out in (7).

non-leave-out variance estimator is based oñ

for it ∈ G g . The leave-out version is defined as 68

Our leave-out strategy differs from leave-out variance estimation procedures of Mackinnon and White (1985) and Kline et al. (2020) . Those papers assume that the OLS parameter vector is still identified when dropping individual units. In fact, Lemma 1 in Kline et al. (2020) shows that unbiased variance estimation is impossible outside that case. Our results, in contrast, provide conservative inference in models where that condition is violated. Indeed, the imputation estimator of Theorem 2 is a special case of Theorem 1 for the model in which each treated observation gets its own treatment effect parameter τ it . Naturally, τ it cannot be unbiasedly estimated without unit i in the data, and thus the results from Kline et al. (2020) do not apply. While computingτ LO it directly may be computationally intensive, a more efficient procedure is available based on a simple rescaling of residualsε it in Equation (7). For it ∈ G g consider

Then replacingε it withε LO it in Equation (7) implements the leave-out adjustment (the proof is based on straightforward algebra and available by request). The leave-out variance estimator based onε LO it is available as an option in our did_imputation command.

When all residuals use only out-of-cluster observations for estimating δ, too, the resulting variance estimator is exactly unbiased for an upper bound on the true variance:

Proposition A7. Assume thatτ w is unbiased for τ w and that the variance ofτ w is estimated bŷ

In this section we provide a computationally efficient algorithm for computing the weights v * it corresponding to the Theorem 1 estimator. We first establish a general result about the weights underlying any linear combination of estimates in any regression: that the weights can themselves be represented as a linear combination of the regressors, with certain coefficients. We then characterize a system of equations for those coefficients and modify the iterative procedure for computing OLS 68 It is well-defined whenever there are no groups in which only one unit receives a non-zero total weight. estimators with high-dimensional fixed effects (e.g. Guimarães and Portugal, 2010) to obtain them.

Proposition A8. Consider some scalar estimatorψ w = w ψ obtained from an arbitrary pointidentified OLS regression y j = ψ z j + ε j . Like every linear estimator, it can be uniquely represented asψ w = v y, with y collecting y j and with implied weights v = (v j ) j that do not depend on the outcome realizations. Then weights v j can be represented as a linear combination of z j in the sample, i.e. v j = z jψ for some vectorψ, the same for all j.

We now apply this proposition to Theorem 1, with the general model of Y it (0) = Z it π + ε. Then

It remains to find the unknownπ andθ to obtain the v * weights. To do so, we use the properties of

∈ Ω, as in that caseθ j = 1 andθ −j = 0. Thus we have a system of equations which determineπ andθ:

When Z it has a block structure in which some covariates are FEs, solving this system iteratively is most convenient and computationally efficient. For instance, suppose Z it π ≡ α i +X it δ and Γ = I N 1 (i.e. Assumption 3 is trivial). Then Proposition A8 implies v * it =α i + X itδ + D itθ it for all it ∈ Ω, and (15) simplifies to v * it = w it for all it ∈ Ω 1 . Using this and the structure of Z it , we rewrite (14) as a system t, it∈Ω 0

This system suggests an iterative algorithm, similar to iterative OLS (e.g. Guimarães and Portugal, 2010) :

1. Given a guess ofδ, setα i for each unit to satisfy (16); 2. Givenα i , setδ to satisfy (17);

3. Repeat until convergence.

To illustrate how the imputation estimator generates efficiency gains relatives to the alternative robust estimators without strengthening the parallel trend assumption, we extend the Table 1 

This rules out non-parallel trends and anticipation effects for units B and C. However, these estimators would stop short of also using Y C3 − Y C1 as a comparison to Y B3 − Y B1 to estimate τ B3 . The imputation estimator leverages this comparison, and therefore increases efficiency without stronger assumptions.

We note that the assumptions underlying other versions of the Callaway and Sant'Anna (2021) estimator are weaker. Marcus and Sant'Anna (2020) explain that in the version that only uses never-treated units as reference group treatment effects are just-identified, and thus the imputation estimator cannot deliver an efficiency gain; in this case, the Callaway and Sant'Anna (2021) estimator is equivalent to the efficient imputation estimator based only on the set of observations on which parallel trends are imposed (i.e. those with t ≥ E i − 1 or E i = ∞). However, this minimal paralleltrend assumption depends on the realized event timing and is not testable. As discussed in Section 2, we prefer the stronger Assumption 1, which can be made a priori and allows for pre-trend testing.

Proposition A9. Suppose there are no never-treated units. Then all linear estimatorsτ w of τ w that are unbiased under Assumptions 1 and 2 with a trivial Assumption 3, and thus robust to arbitrary treatment effect heterogeneity, have the same sensitivity to linear anticipation trends. Specifically, if

This result implies, as we argue in Footnote 44, that there cannot be a general ranking in the sensitivity of different estimators to anticipation effects. We formalize this intuition by:

Corollary A1. For an estimatorτ w of τ w that is unbiased under unrestricted treatment effect heterogeneity and y 0 ∈ R dim Ω 0 , let Bτ w (y 0 ) be its bias when E [Y 0 ] = y 0 , potentially violating Assumptions 1 and 2. Consider two such linear estimators,τ A w andτ B w , and supposeτ A w is more biased for some y 0 : BτA w (y 0 ) > BτB w (y 0 ) . Then there existsỹ 0 ∈ R dim Ω 0 such that the comparison is reversed, BτB w (ỹ 0 ) > BτA w (ỹ 0 ) .

In this extension we show how the approach in the main paper applies when event times E i are stochastic. Moreover, the set of observations Ω may be stochastic too-e.g. due to the stochasticity of the set of periods for which the data are missing (as in the case of panels trimmed around the event time). We continue to make no random sampling assumptions. The main results in the paper go through by conditioning on I = ({E i } i , Ω). That is:

• The target is defined as w 1 τ where w 1 is a function of I-such as the average treatment effect one period after treatment for the set of units for which the outcomes are available both one period after and in some periods before treatment;

• Assumption 1 is reformulated as

is the same across units; Assumption 1 is rewritten in a similar way;

• Assumption 4 is reformulated in a conditional way: E [εε | I] = σ 2 (I)I N (I) ;

• Theorems 1 and 2 guarantee efficiency in the class of linear conditionally-on-I unbiased estimators.

In this section, we show that the fixed-effect model in Section 2 (or, more precisely, Appendix A.10)

can be obtained from parallel-trend assumptions formulated in terms of group-wise averages in a population model with randomly sampled units. Our model in Section 2 is therefore more general; it captures common sampling and parallel-trend assumptions, while it allows for more flexible modeling of heterogeneity and may be preferable when the panel is incomplete.

To relate our approach to random sampling with parallel trends, assume now that for a given number T of periods we observe a complete panel of I units with outcomes Y i = (Y i1 , . . . , Y iT ) and

treatment time E i . We write Y i (0) = (Y i1 (0), . . . , Y iT (0)) for the corresponding vector of potential outcomes if the unit was never to be treated, and D it = 1 [t ≥ E i ] for the treatment status of unit i in period t. We assume that (Y i, , Y i (0), E i ) are iid across units. We can then impose assumptions on the distribution of (Y i, , Y i (0), E i ):

This formulation is similar to those in e.g. de Chaisemartin and D'Haultfoeuille (2020); Sun and Abraham (2021); Callaway and Sant'Anna (2021) , although details vary about the cohorts and periods for which parallel trends are assumed (see Section 4.5). In this model, once we condition on event timing {E i } i , we obtain the assumptions from Appendix A.10 with unit fixed

, and treatment effects

where unit-fixed and treatment effects do not vary within cohorts. Any variation in Y it − Y it (0) within cohorts is attributed to the mean-zero error terms ε it in the regression

Thus, iid sampling, a parallel-trend assumption defined on the cohort level, and a complete panel jointly imply our assumptions in Section 2.

Relative to a sampling-based approach, we see three main advantages of our more general conditional fixed-effects model. First, considering units individually allows us to estimate their treatment effects separately, which permits the estimation of weighted treatment effect sums that put nonconstant weights on units with the same relative event time (e.g. when estimating the gap between average treatment effects for men and women two periods since the treatment onset). Second, we can more naturally capture settings in which the convenience assumption of sampling from a population is unrealistic, such as when we observe all US states. Third, our unit fixed-effects model can handle missing observations even when the composition of units changes over time, while cohortbased parallel trend assumptions (e.g. that

be unattractive; similarly, estimation with cohort, rather than individual, fixed effects can lead to biases with incomplete panels.

To complement the results in Section 6.3 obtained from a single sample, we further validate them with a Monte Carlo study. We choose a data-generating process (DGP) that closely resembles the actual data, using wild clustered bootstrap. Specifically, we obtain residualsε it as in Section 4.3 and simulate the errors as ε * it = z * iε it , for z * i drawn independently across households and taking values ±1 with equal probabilities. Panel A of Figure A4 plots the true standard deviations of the three alternative estimators for this DGP, computed as in Section 4.6, while Panel B normalizes them by the standard deviation of the imputation estimator. 69 The efficiency gains are very similar to those from Figure 7 : the standard deviation of the dCDH estimator is about 50% larger than that of the efficient imputation estimator, and 2 to 3.5 times larger for Sun and Abraham (2021). In an unreported robustness check we find similar efficiency gains with homoskedastic errors ε * it .

In this appendix, we collect proofs for the results in the main text and in the appendix. We first restate the matrix notation from Section 4 for convenience. Specifically, we stack the vectors

to summarize the nuisance component of the model. In matrix-vector notation, we write Y for the vector of outcomes, Z = (A, X) for the covariate matrix, D for the matrix of indicators for treated units, ε for the vector of error terms, and Σ = Var [ε] for their variance. We write Y 1 , Z 1 = (A 1 , X 1 ), D 1 , ε 1 for the rows corresponding to treated observations (it ∈ Ω 1 ); in particular, D 1 = I. Analogously, we write Y 0 , Z 0 = (A 0 , X 0 ), D 0 , ε 0 for the rows corresponding to untreated observations (it ∈ Ω 0 ); in particular, D 0 = O. We write τ = (τ it ) it∈Ω 1 for the vector of treatment effects of the treated units,

for the vector of underlying parameters, Γ = (Γ it,j ) it∈Ω 1 ,j∈{1,...,N 1 −M } for the matrix linking the two, and w 1 = (w it ) it∈Ω 1 for the weight vector. Then we can write model and estimand 69 The tight connection between the chosen DGP and the actual data reveals itself in the fact that the standard deviation of the imputation estimator in Figure A4 is identical to its in-sample clustered standard error from Figure 7 . This is not the case for the other estimators, making our Monte Carlo analysis informative. 

and denote by Σ i = Var [ε i ] the within-unit variance-covariance matrix of error terms.

Proof of Proposition 1. In the absence of never-treated units and defining τ −1 = 0, we can write

Now consider some collection of τ h (with τ −1 = 0) and FEsα i andβ t . For any κ ∈ R, let

Then for any observation it,

and Equation (2) 

We have it∈ΩD it α i = i α i t;it∈ΩD it = 0 because the residuals in the auxiliary regression are orthogonal to all unit indicators. Analogously, it∈ΩD it β t = 0. Defining

we have that τ static = it∈Ω w OLS it τ it D it = it∈Ω 1 w OLS it τ it , as required. Clearly, w OLS it do not depend on the outcome realizations. Moreover, these weights add up to one because we have that

where the last equality holds becauseD it are orthogonal to the unit and period FEs.

Proof of Proposition 3. We use the characterization of OLS weights in Equation (18). Given the complete panel, the regression of D it on TWFE produces residuals

i=A,B 3 t=1 D it (de Chaisemartin and D'Haultfoeuille, 2020). Plugging inD A· = 2/3,D B· = 1/3,D ·1 = 0,D ·2 = 1/2,D ·3 = 1, and D ·· = 1/2, and computing it∈Ω 1D it = 1/3, we havê

Similarly, the OLS estimand equals

Proof of Proposition 4. Let I be the total number of units and I ever be the number of ever-treated units (i.e., those treated by t = T ). As in the proofs of Propositions 2 and 3,

where the last expression holds because treated observations are those belonging to ever-treated units in periods since E first , excluding the N * 0 pre-treatment observations in those periods. SinceD i· monotonically declines in E i andD ·t increases in t, Equation (19) implies that the lowest weight on any treated observation corresponds to E i = E first and t = T . Thus, there is no negative weighting if and only ifD it ≥ 0 for such observations. Considering Equation (19) for one of those observations and usingD ·T = Iever I , there is no negative weighting if and only if

where the second line simplifies the terms, and the last line uses the definition of N * 1 . This is equivalent to N * 1 ≥ N * 0 , as required.

Proof of Proposition 5. For any observation it,

Thus, all observations considered by the estimand correspond to the periods in which all units are already treated. Consider one such period t for which the total weights are nonzero, i : K it ≥H w it = 0. (It exists because all weights w it are assumed non-negative and are not identically zero.) Then consider a data-generating process in which β t is replaced with β t − κ for some κ = 0 and τ it is replaced with τ it + κ for all i. This DGP is observationally equivalent in terms of the observed Y it and continues to satisfy Assumptions 1 and 2. Yet, the estimand differs by any arbitrary κ i : K it ≥H w it = 0, and is therefore not identified.

Proof of Theorem 1. The result is a consequence of the Gauss-Markov theorem. By itself, the Gauss-Markov theorem establishes the efficiency of the underlying OLS estimator for θ. Here, we extend efficiency of the estimation of θ to efficiency for the estimation of the weighted sum of treatment effects τ w = w 1 Γθ. By construction,τ * w = w 1 Γθ * for the OLS estimatorθ * of θ. For every linear estimatorτ w that is unbiased for τ w for all θ there is a linear unbiased estimatorθ of θ (with variance Σθ) for whichτ w = w 1 Γθ, for example the estimatorθ =θ * +Γ w 1 (w 1 ΓΓ w 1 ) −1 (τ w −w 1 Γθ * ) (where we assume that Γ w 1 = 0, since the estimand and efficient estimator are otherwise zero).

Indeed, for that choice,

Under homoskedasticity, the OLS estimatorθ * is the best linear unbiased estimator for θ in the regression Y = Zπ + DΓθ + ε, with variance Σθ * that is minimal (in the partial ordering implied by positive semi-definiteness) among the variances of linear unbiased estimators of θ by Gauss-Markov.

Hence, Var(w 1 Γθ * ) − Var(w 1 Γθ) = w 1 Γ(Σθ * − Σθ)Γ w 1 ≤ 0, establishing efficiency. The efficient linear estimator of τ w is also unique; indeed, if there was some unbiased linear estimatorτ w with

would be an unbiased linear estimator with lower variance.

It remains to argue unbiasedness in the heteroskedastic case. Since the OLS estimatorθ * remains unbiased for θ even without homoskedasticity, so doesτ * w = w 1 Γθ * for τ w = w 1 Γθ.

Proof of Theorem 2. The efficient estimator from Theorem 1 is obtained from the OLS estimator τ * of τ in Y = Zπ + Dτ + ε by settingτ * w = w 1τ * . We now show that the OLS estimatorτ * w has the desired imputation form. By Frisch-Waugh-Lovell applied to residualization of Y and Z with respect to D, the OLS estimateπ * of π in the linear regression Y = Zπ + Dτ + ε is the same as the estimate of π in the linear regression Y 0 = Z 0 π + ε restricted to Ω 0 . Indeed,

The OLS estimatorτ * of τ in Y = Zπ + Dτ + ε is the same as the OLS estimator in the regression of Y − Zπ * on D. This is because (π * ,τ * ) minimize the sum of squares Y − Zπ − Dτ 2 over choices of (π,τ ), andτ * therefore minimizes Y − Zπ * − Dτ 2 overτ givenπ * . We can therefore writê

which has the desired imputation form.

Proof of Proposition 6. As in the proof of Theorem 1, there exists an unbiased linear estimatorτ of τ such thatτ w = w 1τ . We now construct a linear estimatorĈ that is unbiased for Z 1 π, does not depend on Y 1 , and yieldsτ w = w 1 (Y 1 −Ĉ). To this end, letĈ = Y 1 −τ . ThenĈ is a linear estimator

SinceĈ is linear, we can writeĈ = U Y 1 + V Y 0 for matrices U, V .

Since

for all τ, π, we must have U = O. Therefore,Ĉ satisfies the requirement of the proposition.

Proof of Proposition 7. Writing v i = (v it ) t , consistency follows from

where the first case covers the condition i t;it∈Ω |v it | 2 → 0 from Assumption 6 and the second case covers the alternative condition

Proof of Proposition 8. Writeτ

Write p = 2 + κ and let q be the solution to 1 p + 1 q = 1 (so in particular 1 < q < 2 < p). Using Hï¿oelder's inequality to establish that, for any i,

and using E [|ε it | p ] ≤ C and p q + 1 = p, we have that

Hence,

where we have used that lim sup v 2 H /σ 2 w < ∞ and that i

→ 0, and so by the Lyapunov central limit theorem we have that

Proof of Theorem 3. We have that

Since the estimatorτ w is invariant with respect to a change in λ i , and λ i only appears within unit i with covariates A i , we must have that

We now want to show convergence ofσ 2 w by establishing consistency ofσ 2

with respect to σ 2 w + σ 2 τ and showing thatσ 2 w is close toσ 2 w . We proceed in three steps. First, we consider consistency ofσ 2 w . Note that for any i

is bounded from above, which we will later use to bound the difference betweenσ 2 w andσ 2 w . To establish a bound, note that

where the second line used that

Hence, v −2

Proof of Proposition A1. Sinceτ w is linear by assumption we can writeτ

for any θ and π. Hence, Γ v 1 = Γ w 1 and v 1 Z 1 + v 0 Z 0 = 0 . It follows thatτ w is an unbiased estimator of τ v = v 1 τ for all τ . The remaining part of the proposition is a direct consequence of Proposition 6.

Proof of Proposition A2. Write Φ Z = I − Z(Z Z) −1 Z for the annihilator matrix with respect to the control variables, then

By the Frisch-Waugh-Lovell theorem for the OLS estimatorθ of θ in Theorem 1,

and, since v * Y =τ * w = w 1 Γθ, using D = I O , and plugging in the expressions for Φ, Φ 0 ,

as required by the proposition.

In the special case of Γ = I N 1 , Γ(Γ ΦΓ) −1 Γ = Φ −1 (where we note that Φ is invertible by the assumption that τ is identified, which requires that Φ Z D is not collinear or, equivalently, that

To simplify Φ 0 Φ −1 , we note that

and thus, plugging in for (Z Z) −1 Z 1 ,

which shows the expression for Γ = I N 1 and thus concludes the proof.

Proof of Proposition A3. We show that the weights from Proposition A2 are the same as those stated in the proposition. We can solve the optimization problem for v * 1 from the Lagrangian relaxation

with the first order condition Γλ = Φ −1 v, which is solved for v * 1 = ΦΓ(Γ ΦΓ) −1 Γ w 1 (as claimed) with λ = (Γ ΦΓ) −1 Γ w 1 . Here, Φ −1 can be written as the variance Var # [τ * ] of the OLS estimator τ * of τ with unrestricted heterogeneity, homoskedasticity, and unit variance, which is The weight on Y 0 is then implied by imputation. Indeed, the imputation estimator from Theorem 2

by Proposition A2 with Γ = I N 1 . Given v * 1 = ΦΓ(Γ ΦΓ) −1 Γ w 1 , this yields the same weights Φ 0 Γ(Γ ΦΓ) −1 Γ w 1 on Y 0 as v * 0 in the proof of Proposition A2 (as claimed).

Proof of Proposition A4. In order to establish consistency, we show that the Herfindahl condition from Assumption 6 is fulfilled forτ * w , that is, v * 2 H → 0, which allows us to invoke Proposition 7. As a preliminary result, note that for any b ≥ 1, S ∈ Z + , and any a 1 , . . . , a S , Jensen's inequality

Assume without loss of generality that β 1 = 0. To bound the weights v * it , we consider the alternative unbiased linear estimator

of the unit and period fixed effects. Since it∈Ω 0 v * it Y it is the best linear unbiased estimator for (− it∈Ω 1 w it (α i + β t )) under homoskedasticity, we can bound the sum of squares weights it∈Ω 0 (v * it ) 2 since they are the same as the variance 

under Assumption A4, which implies the Herfindahl condition (Assumption 6) and thus consistency by Proposition 7.

Proof of Proposition A5. In order to establish asymptotic Normality, we want to establish that i t;it∈Ω |v it | v H 2+κ → 0 for κ = 2 (Assumption A1), which allows us to invoke Proposition 8.

, so we can expresŝ

where the u it are defined as the weights on the Y it , it ∈ Ω 0 in T t=2 i;D it =0 s;D is =1 w it s;D is =0 1 − i;D it =1 w it β t , and we write E i = T + 1 for the never-treated cohort. Hence, we can write

It follows with (20) in the previous proof for b = 2 + κ = 4 that

We now consider the two parts of this sum. First, note that there is only a finite number of cohort-period cells et with E i = e ≥ t, and within every such cell

For the second part of the sum, the u it only depend on cohort and period (since the period fixed effects are invariant to exchanging unit identities within cohorts), u it = U E i ,t , so similarly, for vanish for all e and t we now derive that

2+κ 2 also vanishes. To this end, we note that

Using (21), we obtain that

At the same time, it∈Ω v * it 2 ≥ it∈Ω 1 w 2 it . Putting everything together, we conclude that → 0.

Since also v 2

yielding Assumption A1. This allows us to invoke Proposition 8 to obtain asymptotic Normality.

Proof of Proposition A6. We show that the assumptions of this proposition imply the assumptions of Theorem 3, which guarantee that standard errors are asymptotically conservative. The two proceeding proofs (of Propositions A4 and A5) establish that Assumptions 6 and A3 hold. It

We assume throughout that the first time-fixed effect is dropped, β 1 = 0, which is without loss since it does not affect the estimator or the construction of standard errors. We first consider the left

, with the correspondingτ it ≡τ . In this case,

Whenτ it are cohort-horizon cell averages,

We finally consider the expression in (22) involving the time fixed effectsβ t . Here,

From these three expressions, we conclude that

We now bound the three variances above. Each of them contains a linear estimator. Such a linear estimatorη = it∈Ω a it Y it has variance

We can therefore bound it by Tσ 2 times the variance Var # (η) = it∈Ω a 2 it in data with uncorrelated and homoskedastic errors terms with unit variance. In such data, the estimatorsτ it andβ t have minimal variance (by Gauss-Markov), which extends to their weighted averages as in the proof of Theorem 1. Under Var # , we can therefore bound the respective variances by the variances using any other linear unbiased estimators of the τ it and β t . Recalling that we normalized β 1 = 0, we can use the estimators

where we have repeatedly used the Cauchy-Schwartz inequality and that weights do not vary too much within cohort-period cells. Similarly, for each e and t ≥ e,

Finally, for each t,

Putting everything together,

v 2 H C 2 min e j;E j =e 1 + 

Notes: This table shows the evolution of expected outcomes over three periods for three units (or cohorts), for the illustrative example of Appendix A.8. Notes: For the numerical example described in Appendix A.1 this figure reports the total weight that thê τ h estimator from the semi-dynamic TWFE OLS regression, for each horizon h = 0, . . . , 3, places on the treated observations from each cohort e observed h periods after treatment. The horizontal axis and the lines correspond to the cohort e and horizon h, respectively. Panel A trims the sample to include observations with K it ∈ [−4, 3] only, while Panel B includes all data (but does not report the weights for the coefficients τ 4 , . . . , τ 7 ). The weights placed byτ h on observations at horizons other than h (as described in Section 3.5) are not shown. Table 2 . The specifications do not interact week FEs with disbursement methods. Panel B reports the ratios of the standard deviations for dCDH and SA relative to the imputation estimator.

Synthetic control methods for comparative case studies: Estimating the effect of California's Tobacco control program

The nonparametric identification of treatment effects in duration models

Economic Activity and the Spread of Viral Diseases: Evidence from High Frequency Data

Estimating the labor market impact of voluntary military service using social security data on military applicants

Mostly harmless econometrics: An empiricist's companion

Double-Robust Two-Way-Fixed-Effects Regression For Panel Data

Design-based Analysis in Difference-In-Differences Settings with Staggered Adoption

Do free trade agreements actually increase members' international trade?

How Much Should We Trust Staggered Difference-In-Differences Estimates?

Debt and the response to household income shocks: Validation and application of linked financial account data

Deleting a Signal: Evidence from Pre-Employment Credit Checks

Can Policy Change Culture? Government Pension Plans and Traditional Kinship Practices

A second chance? Labor market returns to adult education using school reforms

Revisiting Event Study Designs

The economic stimulus payments of 2008 and the aggregate demand for consumption

Difference-in-Differences with Multiple Time Periods and an Application on the Minimum Wage and Employment

The Effect of Minimum Wages on Low-Wage Jobs

Linear Models with High-dimensional Fixed Effects: An Efficient and Feasible Estimator

Two-way fixed effects estimators with heterogeneous treatment effects

Difference-in-Differences Estimators of Intertemporal Treatment Effects

Noise, Cognitive Function, and Worker Productivity

Stock Market Returns and Consumption

The Market Impacts of Pharmaceutical Product Patents in Developing Countries: Evidence from India

Household Responses to Severe Health Shocks and the Design of Social Insurance

MPC heterogeneity and household balance sheets

Two-stage differences in differences

Regional policy evaluation: Interactive fixed effects and synthetic controls

Difference-in-differences with variation in treatment timing

A simple feasible procedure to fit models with highdimensional fixed effects

Long Run Impacts of Childhood Access to the Safety Net

A Panel Data Approach for Program Evaluation: Measuring the Benefits of Political and Economic Integration of Hong Kong with Mainland China

Causal inference in statistics, social, and biomedical sciences

Household expenditure and the income tax rebates of

A Model of the Consumption Response to Fiscal Stimulus Payments

The Marginal Propensity to Consume in Heterogeneous Agent Models

Leave-Out Estimation of Variance Components

Excess sensitivity of high-income consumers

A Simple Mapping from MPCs to MPXs

Testing statistical hypotheses

A Practical Guide to Counterfactual Estimators for Causal Inference with Time-Series Cross-Sectional Data

Even Studies in Economics and Finance

Some heteroskedasticity-consistent covariance matrix estimators with improved finite sample properties

The role of parallel trends in event study settings: An application to environmental economics

Intertemporal Labor Supply Substitution? Evidence from the Swiss Income Tax Holidays

FEffects of the Minimum Wage on Employment Dynamics

The Persistent Effect of Temporary Affirmative Action

Micro MPCs and Macro Counterfactuals: The Case of the 2008 Rebates

Household Spending Responses to the Economic Impact Payments of 2020: Evidence from the Consumer Expenditure Survey

An Honest Approach to Parallel Trends

Pre-test with Caution: Event-study Estimates After Testing for Parallel Trends

Working Paper, 2020. and , "Efficient Estimation for Staggered Rollout Designs

Pink work: Same-sex marriage, employment and discrimination

H (σ 2 w + σ 2 τ ) is bounded. Together with the previous point, it follows thatThird, we bound the difference betweenσ 2 w andσ 2 w byTo bound the first term and the first factor of the second term, note that→ 0 and Assumption A2 holds. We established in the second step that the second factor of the last term is asymptotically bounded in probability. Therefore v −2 H σ 2 w −σ 2 w p → 0. Combining the first and the third step, we conclude thatThese data satisfy Assumptions 1 and 2 with the corresponding τ it = − (κ 0 + κ 1 K it ) for it ∈ Ω 1 , and thusProof of Corollary A1. Without loss of generality, suppose BτA w (y 0 ) > 0, and thus BτA w (y 0 ) > BτB w (y 0 ). Proposition A9 implies that there exists a set of violations of Assumptions 1 and 2, y 0 ∈ R dim Ω 0 , such that BτA w (y 0 ) = BτB w (y 0 ) > BτA w (y 0 ). Since B is linear in y 0 for any linear estimator, this implies 0 < BτA w (y 0 − y 0 ) < BτB w (y 0 − y 0 ), which concludes the proof withỹ 0 = y 0 − y 0 . Notes: Panel A reports MPX coefficients and 95% confidence bands using the imputation estimator for subsamples based on household characteristics, in parallel to Tables 7 and 8 of Broda and Parker (2014) . Figure ( i) splits households into three groups by 2007 household income: below $35,000 ("low"), between $35,000 and $70,000 ("medium"), and above $70,000 ("high"). Figure ( ii) splits them into two groups according to the survey question: "In case of an unexpected decline in income or increase in expenses, do you have at least two months of income available in cash, bank accounts, or easily accessible funds?" Answer "No" corresponds to low liquidity, and "Yes" to high liquidity. All specifications include interactions between disbursement method and week FEs. In Panel B, the MPX estimates in dollars are rescaled by the average tax rebate amount in each household group.